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ABSTRACT
MICHAEL J. LEE: Activation of G Protein Signaling by a Non-Receptor Exchange Factor
(Under the direction of Dr. Henrik G. Dohlman)
 G proteins are biological signaling switches, which typically exist in a multi-protein
complex at the cell periphery. Included in these systems is a seven-transmembrane spanning
G protein coupled receptor (GPCR), a guanine nucleotide binding protein G alpha subunit
(Gα) and the obligate dimer Gβγ. GPCRs bind extracellular ligands, and transmit signals to
intracellular G proteins.  Ligand binding causes the Gα subunit to exchange GDP for GTP.
GTP-bound Gα no longer interacts with Gβγ, and both entities are free to interact with
downstream effector proteins.  Gα regulates the duration of the signal because Gα is a
GTPase, an activity that can be accelerated by GTPase Accelerating Proteins (GAPs) such as
RGS proteins.
The standard G protein signaling model, in its basic tenets, has remained largely
unchanged for decades.  This paradigm, however, fails to take into account recent findings
that G proteins are not restricted to the cell periphery.  A number of reports suggest that Gα
subunits in particular exist at, and even signal at, intracellular locations.  These findings open
up the possibility that Gα subunits regulate novel signaling pathways, away from the cell
periphery, and potentially independent of the traditional “Gα-Gβγ-GPCR” paradigm. One
particular example comes from the yeast model system, where the G protein Gpa1 regulates a
cell fusion process called mating.  It was recently identified that Gpa1 regulates a Gβγ-
mediated signal at the cell periphery, and PI3K-mediated signal from the cell interior.
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Studies presented in this thesis focus on: 1) the regulation of Gpa1 signaling by post-
translational modifications such as palmitoylation and ubiquitination, and 2) the activation of
Gpa1 by non-receptor activators. Specifically, we detail the discovery that Arr4 functions as
an exchange factor for Gpa1, and may contribute to the activation of Gpa1 at the endosome.
Also, we find that Gpa1 localization to the plasma membrane and endosome is regulated by
multiple forms of ubiquitination and also by dynamic palmitoylation.  Finally, we create a
novel method to be used for the identification of proteins involved in palmitoylation.
Collectively, these discoveries further the growing understanding that G proteins function at
intracellular locations.
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2The ability for an organism or cell to interpret and respond to changes in its
immediate environment is one of the critical processes that allow for sustained life.
Environmental cues are processed at the cellular level by a number of different signaling
systems, but throughout biology, no system is more widely used than those coupled to
heterotrimeric G proteins.  The receptors of these systems alone encode over 1% of the
human genome, and account for the single largest family of genes (55, 149).  Heterotrimeric
G proteins and their associated receptors respond to a wide array of signals, including
neurotransmitters, hormones, tastes, odors and light (5, 20, 23).  In accordance with the fact
that G proteins regulate many aspects of human physiology, defects in these systems are
known to contribute to a number of human diseases (51).  To date, it has been estimated that
approximately 30% of all drugs currently on market target GPCRs, and this number is
increased to approximately 50% if we include signaling components targeted downstream or
upstream of GPCRs (169). Thus, it is self-evident that a more complete understanding of G
protein signaling will help in the identification of new drug targets and the generation of new
drug therapeutics.
HETEROTRIMERIC G PROTEIN SIGNALING
Heterotrimeric G proteins are a biological signaling switch, which typically exist in a
multi-protein complex at the cell periphery (61).  Included in these systems is a seven-
transmembrane spanning G protein coupled receptor (GPCR), a guanine nucleotide binding
protein (G protein) alpha subunit (G?), and the obligate dimer comprised of G? and
G? (often written as G??).  Signaling through these systems is controlled by the differential
binding of GDP/GTP by G?, and the signaling cycle can be considered as four distinct steps
3(Figure 1.1).  In the first step, the basal state, G? is bound to GDP, is considered inactive,
and in this conformation also interacts with G??.  Ligand binding to the GPCR (step 2)
causes the receptor to function as a guanine nucleotide exchange factor (GEF).  The active
receptor stabilizes the nucleotide-free form of G?, allowing for release of GDP, which is
replaced with the more abundant molecule GTP.  Nucleotide release is the rate-limiting step
in the signaling cycle (53).  GTP-bound G? is considered active, and no longer interacts with
G??.  Both entities are then free to regulate downstream signals (step 3).  The G? subunit is a
GTP hydrolase, allowing for inactivation of the pathway (step 4).  Hydrolysis is often aided
by members of the regulator of G protein signaling (RGS) family of proteins (121, 133),
which function as GTPase accelerating proteins (GAPs) by stabilizing the transition state of
hydrolysis (13).  Once GTP is hydrolyzed to GDP, the inactive G?-G?? heterotrimer is
reformed.
This standard model, in its basic tenets, has remained largely unchanged for decades.
This paradigm, however, fails to take into account recent findings that G proteins are not
restricted to the cell periphery.  A number of reports suggest that G? subunits in particular
exist at, and even signal at intracellular locations (7, 136, 146, 157, 175).  These findings
open up the possibility that G? subunits regulate novel signaling pathways, away from the
cell periphery, and potentially independent of the traditional “G?-G??-GPCR” paradigm.
This thesis will focus on two aspects of G? biology that are related to novel functions of
intracellular G? subunits:  G? activation and G? trafficking.  In this introductory chapter,
special attention will be paid to the yeast G? subunit Gpa1, the focus of this thesis.
G alpha subunits. G? subunits are part of a larger superfamily of GTPases, which
also includes “small” G proteins such as Ras and its homologs (141).  All proteins in this
4superfamily contain a conserved structural motif, the Ras-like domain, suggesting a common
evolutionary origin of these proteins.  Heterotrimeric (or “large”) G proteins contain two
distinct domains:  the Ras-like domain that is conserved among all GTPases, and an
independently folded six-helix bundle, often referred to as the all-helical domain (170).
Based on the resolved crystal structures of GDP and GTP bound G? subunits, it is clear that
activation results in movement in three flexible loops, called switch regions (designated I-
III).  For small GTPases, it is known that GEFs function by making direct contact with these
switch regions (141).  Although similar movements must occur in heterotrimeric G proteins,
it is not clear how receptors (or non-receptor GEFs) are able to cause these rearrangements.
This continues to be one of the unresolved mysteries in heterotrimeric G protein biology.
MODEL SYSTEMS FOR STUDYING G PROTEIN SIGNALING:  THE YEAST
PHEROMONE-INDUCED MATING RESPONSE
Because of the complexity of G protein mediated signal networks in mammalian
cells, the G protein field has benefited greatly from studies performed in simpler eukaryotic
organisms such as C. elegans and S. cerevisiae.  Yeast in particular has been an invaluable
resource because of: 1) the advantages of genetically manipulating an organism that can exist
stably as a haploid or diploid, 2) the efficiency of homologous recombination in yeast, 3) the
existence of a fully sequenced genome, and 4) the availability of a number of genomic tools
such as knock out libraries, GFP-tagged libraries, and epitope-tagged libraries.
With regard to heterotrimeric G protein signaling, the yeast system has been very well
characterized (Figure 1.2) (41).  In yeast, G proteins control the fusion of two haploid cells to
create a diploid cell. Yeast can exist as haploid cells of either the a- or ?- mating type and
5secrete mating pheromones, a-factor and ?-factor, respectively.  Binding of pheromone to
receptors on adjacent cells induces growth arrest in G1, polarized growth towards the mating
partner, and new gene transcription in preparation for cell fusion. Most of the components of
this signaling cascade were identified genetically as deletions that resulted in a mating-
deficient (sterile) phenotype. Included are genes that encode a GPCR (STE2), G? and G?
subunit (STE4 and STE18), but not a G?.  Deletion of Gpa1, the G? of the mating pathway,
does not result in a sterile phenotype, but rather a constitutively active signal, due to the
uncontrolled activation of G??  (37, 105).  Subsequent data showing that G?? was both
necessary and sufficient to activate the mating signal left the conclusion that G? played no
active role in this process.  Recent evidence, however, suggests that Gpa1 may play an active
roll in signaling.  Investigating this possibility is a central focus of this thesis.
HETEROTRIMERIC G ALPHA SUBUNIT: ACTIVATION BY RECEPTORS AND
NON-RECEPTOR EXCHANGE FACTORS
Much of the recent focus in heterotrimeric G protein research has been on the
activation of the G? subunit.  G protein activation is the least understood of the various
stages of G protein signaling (78).  This lack of understanding stems, in large part, from the
absence of a resolved crystal structure of either the empty G? subunit or G?/G?? in complex
with a GPCR.  The main barriers are the inherent instability of nucleotide-free G? subunits
(53), and the difficulty in crystallizing GPCRs alone, let alone in complex with other
proteins.
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7Figure 1.1  The heterotrimeric G protein signaling cycle.  G protein coupled receptors
bind extracellular ligands, and transmit signals to intracellular G proteins.  Ligand binding
causes the G? subunit to exchange GDP for GTP.  GTP-bound G? no longer interacts with
G??, and both entities are free to interact with downstream effector proteins.  G? regulates
the duration of the signal because G? is a GTPase, an activity that can be aided by GAPs
such as RGS proteins.
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9Figure 1.2  The yeast mating response pathway.  In yeast, mating is controlled by a typical
heterotrimeric G protein coupled system.  Gpa1 interaction with Ste4/Ste18, and activation of
a MAPK effector signaling cascade, is regulated by pheromone binding to the receptor Ste2.
Downstream MAPKs are activated directly by Ste4/Ste18.  Gpa1 was thought to play only a
regulatory role in signaling; however, we now know Gpa1 activates Vps34, and endosomal
PI3K.  The mechanism of Vps34 activation is currently unknown.
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Receptor-mediated activation
The central mystery with regard to receptor-mediated activation of G proteins is that
all modeled structures predict a distance of at least 30 Å between receptor-G? contact sites
and the G? switch regions (78).  This distance, which is predicted to be too large to allow for
direct contact of switch regions by the receptor, suggests that heterotrimeric G? subunits and
small G proteins do not share a common mechanism of activation. Various models have been
proposed to account for this discrepancy, either proposing usage of G?? as a “lever,” or
proposing allosteric modulation of switches through the C-terminal ?5 helix of G? (114,
119).  Evidence exists in favor of both of these mechanisms, and recent crystal structures
have suggested the possibility that both models could be correct (78, 79).  Further
complicating the mystery of activation, however, is the fact that GPCRs are not the only
proteins that are known to activate G? subunits.  Although a handful of non-receptor GEFs
have been characterized, a sequence, domain, or structural motif has not been identified to
account for the similar functions of seemingly dissimilar GEFs.
Activation by non-receptor exchange factors
Mastoparan.  The standard—and without question most common—mechanism of
heterotrimeric G protein activation is through agonist activated GPCRs.  Although the notion
that G proteins could be activated by non-receptor GEFs is currently being revisited (65), it
was first addressed 20 years ago by a number of groups—notably by Elliott Ross and
colleagues—when they discovered the non-receptor GEF mastoparan.  The critical
connection came in 1988 when it was identified that wasp venom mastoparan (MP) mediated
histamine release through mobilization of Ca++ and production of the second messenger
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inositol-1,4,5-triphosphate (IP3) (113).  This fact did not go unnoticed by Ross and
colleagues, as this process was already known to be G protein mediated (61).  Work by
Tsutomu Higashijima (while in the Ross lab) identified that, like GPCRs, MP bound directly
to the G protein, accelerated guanine nucleotide exchange, did not alter hydrolysis of bound
GTP (single-turnover), was affected by Mg++ concentration, and was blocked by pertussis
toxin-catalyzed ADP-ribosylation of G? (72, 73).  Subsequent studies identified that MP is a
cationic amphiphilic helix, as are neuropeptide substance P and a synthetic polyamine
compound 48/80. Both substance P and 48/80 were subsequently identified to be GEFs for
G? subunits (106).  Based on the characteristics shared among these peptide GEFs, as well as
the activity they share with receptors, an analogy was drawn to the intracellular loops of
GPCRs.  Ross and others began the argument that mastoparan and the other peptide GEFs
were true “receptor mimics,” suggesting that cationic amphiphilic structure must form in one
or more of the intracellular loops of the receptor (72).
A number of facts have since arisen that call into question the idea that MP is a true
receptor mimic.  For example, in the initial discovery, it was identified that while potent, MP
was not at all selective amongst G? subtypes.  Although not completely incongruent with
being a G? GEF, this is certainly different than what is typically seen for receptors.  Also,
binding studies show that MP makes contacts near the extreme N-terminus of G?, a region
thought to be important for G?? binding but not for receptor interaction.  It is not
inconceivable that a GEF could bind at the N-terminus and simultaneously contact critical
residues in the C-terminus of G?, but this too was nonetheless different from receptors.
Another critical difference was the dependence on G?? for activity.  Studies from Bernard
Fung have shown that GPCRs absolutely require G?? to function as GEFs (56, 57).  MP was
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found to interact with and activate monomeric G? subunits in the absence of G??, and both
the G? binding and the GEF activity was enhanced by the presence of G??.    This subtle
difference in G?? dependence likely suggests that GPCRs and MP activate G? subunits
using different mechanisms.
Two decades after the initial discovery that mastoparan was a G? GEF, very little has
been done to develop this idea.  MP is a wasp venom known to be toxic to cells; however,
research focused on MP as a GEF has suffered from questions about whether the GEF
function was responsible for the toxicity.  Some data exists to suggest that MP toxicity does
not depend on G protein signaling (81).  In addition, even amongst those that consider the in
vivo target to be G? subunits, there is debate about the mechanism of action.  Some reports
suggest that MP binds to and activates nucleoside diphosphate kinases, allowing the
conversion of GDP-GTP (82), and others suggest that MP toxicity results only from
membrane disruption (91).  To date, it is far from a certainty that MP and other cationic,
amphiphilic peptides are truly receptor mimics in vivo, however, their biochemical function
in vitro suggests that these peptides could still be valuable tools for studying G? subunits.
Activation by synthetic peptides.  It was recognized early on that the ability to
crystallize GPCRs would likely be the limiting step in attempts to understand the G protein
activation process.  Even from the early studies on mastoparan, attempts were made to draw
comparisons between MP and GPCRs.  Subsequently, a number of groups created synthetic
peptides as a means of better understanding receptor-mediated activation.  Prominent
examples included MP-S and Galparin, both of which were designed from MP (85, 148). By
the early 90’s Neubig and others began using receptor-derived peptides as tools for studying
G? activation (152).  The fact that some of these peptides retained GEF function gave hope
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that studying peptides could give insight into the mechanism of receptor-mediated activation.
Recently, Siderovski and colleagues used a combination of peptides derived from receptors
and peptides identified using phage display to provide the first structural evidence for how
receptors catalyze GDP release (79, 80).
Non-receptor activation—Ric-8a.  Approximately five years ago, research on
receptor-independent activation of G? subunits was reinvigorated with the discovery of the
non-receptor GEF Ric-8a.  This protein was identified by Kenneth Miller in a genetic screen
in C. elegans, designed to identify mutations that suppressed the neurotoxic effects of
acetylcholinesterase inhibitors (102).  The 21 genes identified in this screen were named RIC,
for resistance to inhibitors of cholinesterase.  The connection to G? came seven years later,
when Al Gilman and colleagues performed a yeast-2-hybrid screen intending to identify
novel G protein signaling factors.  Using G?o and G?s as bait, they identified the mammalian
homolog of Ric-8a (151).  The first clue to the function of this novel regulator was the
binding profile; authors found that Ric-8a bound to a subset of G? subunits in a GDP
selective manner.  The critical discovery, however, was that Ric-8a formed a stable complex
only with nucleotide-free G?.  This was determined using radiolabelled nucleotides and
purified proteins separated by size exclusion chromatography.  Considering that GEFs are
known to stabilize the nucleotide-free form of G proteins, this data all but assured that Ric-8a
was a GEF.  Using various in vitro assays to measure the rate of exchange, Tall et al. found
that Ric-8a was a GEF for Gi, o, and q but not Gs.
One of the subtle discoveries in Tall and Gilman’s initial report was that the GEF
activity of Ric-8a is inhibited by G??.  As mentioned previously, GPCRs are known to
require G?? for activity, while peptide GEFs like mastoparan are enhanced by G??.  The
14
implication of this finding is that Ric-8a is not a “receptor mimic” but rather a new type of
GEF.  Furthermore, this finding raises the possibility that G? could function in a signaling
system that was completely independent from the traditional G?-??-GPCR paradigm.
By autumn of 2004, the Ric-8a story reached new heights.  In a period of one month,
at least five articles were published detailing that during asymmetric cell divisions, G?
proteins regulate differential microtubule force generation in a process that requires Ric-8a
(1, 30), RGS proteins (69, 99), GoLoco domain containing proteins like LGN (43),
microtubule binding protein NuMA (43), and of course a G? subunit.  Comparisons between
these publications revealed a mechanism that is conserved between C. elegans, Drosophila,
and even mammals (65, 167).  These findings, which in many ways depart from the
established G protein paradigms, marked the beginning of an exciting new time in G?
research.
Non-receptor activation—life after Ric-8a.  In the four years since the Ric-8a
discovery, the focus has shifted to determining: 1) how (or maybe if) Ric-8a fits into the
traditional paradigm of G protein signaling, and also, 2) how prevalent are non-receptor
GEFs like Ric-8a.  Addressing the first of these questions, the prevailing theory is that Ric-8a
activation requires prior stimulation of G? by another GEF or in some instances possibly a
GPCR. This model seems likely given the inability of Ric-8a to activate G protein
heterotrimers in vitro.  In this model, activated G? is stabilized in its “G??-free” form and
presented to Ric-8a by a guanine nucleotide dissociation inhibitor (GDI).  Indeed, some
evidence exists in mammalian cells for the modulation of known GPCR-dependent signals by
Ric-8a (95).  These data are consistent with Ric-8a functioning as a GEF in vivo, even in
pathways that contain a known receptor.  One question with this model is why another round
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of nucleotide exchange would be necessary considering that Gα is already liberated and free
to signal.  Of course, one explanation is that activation by Ric-8a alters the timing,
localization or duration of the signal.  Some, however, have questioned the notion that
promoting nucleotide exchange is truly the function of Ric-8a.  A series of reports have
identified that Ric-8a is required for cortical localization of Gα subunits (32, 64, 160), and
some have postulated that membrane targeting, not G protein activation, is the function of
Ric-8a and its homologues.  Another possibility is that Ric-8a may be an important regulator
of both the localization and activation of Gα  subunits.  This question may remain
unanswered until mutants are developed that maintain Gα binding function but have lost
GEF activity in vitro.
The second question that has arisen from the Ric-8a findings is how prevalent are
non-receptor GEFs.  To this end, many have performed screens with the intent of identifying
novel activators.  Baranski and colleagues used a screening approach in yeast to identify non-
receptor activators of heterotrimeric G proteins in a human adipocyte cDNA library (63), and
Lanier and colleagues performed a similar functional screen using an NG108-15 cDNA
library (150).  Both screens utilized the yeast pheromone response pathway, in cells that lack
a receptor.  This is possible because of the high degree of conservation among the various G
protein subunits between yeast and mammals.  In the latter screen, a handful of proteins were
identified and renamed as activators of G protein signaling (AGS).  It is worth noting that
these proteins were named due to functional similarity and do not comprise a protein
“family,” in the sense that AGS proteins are not evolutionarily or structurally related
proteins.  Also, the term AGS does not connote a mechanism.  AGS proteins are divided into
three categories depending on the proposed mechanism of action: Group 1) nucleotide
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exchange dependent mechanisms (i.e. functioning as GEFs), Group 2) exchange-independent
mechanisms (i.e. functioning as GDIs), or Group 3) direct interaction with G?? (15).  Only
one protein—the Ras-related small G protein Dexras/AGS1—has been proposed to be a
GEF, and for the most part, more data is necessary in order to determine the extent to which
AGS proteins function as G protein activators in vivo.
Thus far, the functional screens involving the yeast mating system (described in detail
below) have utilized the yeast signaling backbone, but have not addressed the existence of
endogenous non-receptor activators.  Considering the high degree of conservation between
signaling components in yeast and in higher organisms, the existence of a non-receptor
activator in yeast would imply a greater relevance of these proteins than is currently
understood.  Furthermore, recent studies in the yeast pheromone response have identified that
the G? protein Gpa1 is involved in regulating multiple signaling pathways, with only one
known GEF (135).  It is unclear whether both Gpa1-mediated signals are regulated by the
same GEF, or if other non-receptor GEFs exist in yeast.  These data will be revisited in
greater detail in the next section of this introduction.  As a part of this thesis, we screened for
non-receptor GEFs.  Rather than using a structural criterion (as was commonly done when
identifying GPCRs) or a purely functional criterion (as was done in previous yeast-based
screens), our screen was designed around the physical binding profile exhibited by most
GEFs.  The results of the screen as well as the characterization of the proteins are detailed in
Chapter IV of this thesis as well as in the future directions, Chapter V.
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G? TRAFFICKING: POST-TRANSLATIONAL MODIFICATIONS AND
IMPLICATIONS ON SIGNALING
It is self-evident that proper signaling requires proper protein trafficking.
Historically, however, trafficking was rarely considered a true signaling step, because of a
lack of evidence that the trafficking of proteins was modulated in a signal-dependent fashion
akin to G protein activation or protein phosphorylation.  Recently, many have shown that
signals can be amplified from, or sometimes even initiated from intracellular sites (153).
This type of regulation allows for more refined spatiotemporal signals, and it has been
proposed that “coincidence detection” on endomembranes would allow for reduced signal
crosstalk and increased specificity (118). Two prominent examples are the trafficking of
TGF-? and EGFR.  Both receptors are trafficked in multiple mechanisms (clatherin-mediated
and raft/caveolar-mediated), with different trafficking patterns resulting in the activation of
different pathways (36).  Another well-publicized example is the discovery by Mark Phillips
and colleagues that Ha-Ras is activated specifically at Golgi membranes (14), a finding that
was likened to “life on Mars, cellularly speaking.” (35).  Similar to the reports cited above,
evidence exists for direct GPCR-mediated signals from intracellular locations.  One specific
example is the recruitment of mitogen activated protein kinases (MAPKs) to the endosome
by ?-arrestin (93).  In this report, Lefkowitz and colleagues found that ?-arrestin functions as
a MAPK scaffold, directing signaling to subcellular compartments.  These findings have
forced the signaling community to begin thinking about signaling more three-dimensionally.
The remainder of this chapter will focus on the current state of our understanding of
intracellular signaling, as well as how post-translational modifications regulate protein
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localization.  The focus will be primarily on G? proteins and primarily on modifications that
are regulated during the course of signaling.
Intracellular signaling by G?
Translocation of G?.  G? subunits have long been known to exist at intracellular
locations.  Over the past 20 years, it has become increasingly evident that G? subunits are
present at Golgi apparatus (49), endoplasmic reticulum (7), secretory granules (157),
endosomes (2), and even the nucleus (31).  In these early examples, G? appeared to be
present alone, without a receptor or other components of the heterotrimer. Thus, it was
unclear how—or if—G? is a functional signaling protein at these varied intracellular
locations.  One recent piece of evidence in favor of G? signaling from intracellular sites is
the stimulus-dependent translocation of G? and G?? subunits to endomembranes.  Gautam
and colleagues have used a variety of live cell imaging techniques to visualize the dynamics
of G protein localization.  Using a combination of FRET and FRAP analysis of fluorescently
tagged G proteins, they found that G proteins shuttle rapidly between the plasma membrane
and intracellular endomembranes (25).  The kinetics of this translocation suggested that the
movement was not vesicle mediated, but rather diffusion based.  Furthermore, the
translocation was dependent on palmitoylation, potentially foreshadowing the use of this
lipid modification as a regulated signaling switch (this idea will be further discussed later in
this chapter, as well as in Chapter III and Chapter V of this thesis).  Finally using G?-G??
FRET, the authors found heterotrimer interaction at both the plasma membrane and at the
Golgi.  This suggests the existence of a functional signaling complex at an intracellular
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location.  Without question, the phenomenon of intracellular signaling by G protein
heterotrimers needs to be more rigorously addressed before these results are widely accepted.
G? effectors at intracellular sites. One of the pieces missing from the work by
Gautam and colleagues is the identification of an actual signal or a unique intracellular
effector protein.  Others, however, have found G? binding proteins that exist specifically at
intracellular sites.  Of particular note are a series of findings by Marilyn Farquhar’s group.
Farquhar and colleagues performed a yeast-2-hybrid screen to identify G?i binding partners,
and have identified a number of interesting interactions.  Their findings included GIV (G
alpha Interacting Vesicle associate protein), a protein localized to ER-Golgi transport vesicles
(86), and calnuc, a homolog of calreticulin that is associated with Golgi (90).  The discovery
of calnuc is particularly interesting as this is the only protein to date that is known to
simultaneously associate with mobilized calcium and G? subunits.    In both cases, these
discoveries are in their most preliminary stages, and it is too early to gauge their full impact.
Endosomal signaling by G?.  Perhaps the best evidence for intracellular signaling by
a G? subunit is a discovery by Slessareva et al, detailing signaling at the endosome by the
yeast G?, Gpa1 (136).   In yeast, the belief was that G?? produced the active signal, while
G? only served to regulate G??.  Surprisingly, however, the authors identified that a
constitutively active G? could activate some, but not all, aspects of the pathway.  In an effort
to identify components involved in signaling by Gpa1, they systematically screened deletions
of all non-essential genes in yeast, looking for those that blocked signaling.  Two of the
seven genes identified were Vps15 and Vps34, the regulatory and catalytic subunits of sole
PI3K in yeast.  What made this discovery even more surprising is the fact that Vps15/34 are
believed to exist only at endosomes, where they control protein trafficking (129, 142).  The
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authors went on to find that activated Gpa1 localizes to endosomes, binds directly to Vps34,
and activates the kinase activity of Vps34.  Another critical finding in this work was that the
inactive form of Gpa1 bound directly to the regulatory subunit Vps15.  This was made all the
more interesting because Vps15 shares some structural characteristics with G? proteins, in
that both are predicted to form seven-bladed propeller structures, and both bind selectively to
the GDP-bound form of G?.  The modeled structure of Vps15 suggests that it lacks critical
residues necessary for interaction with G? in the manner of typical G? subunits; thus, the
question of whether Vps15 is truly functioning as a “G?” remains unanswered.
Post-translational modifications of G? subunits   
G? proteins are peripheral membrane associated proteins.  They attach to lipid
bilayers through the use of post-translational N-terminal lipid-acylation (24).  The pattern of
lipidation differs depending on subtype: for example, G?s members are palmitoylated; G?i
members are both myristoylated and palmitoylated; G?t is only myristoylated; and G?q
members are palmitoylated and some are also thought to use an N-terminal poly-basic stretch
in addition to lipidation (166).  In general, G?  subunits adhere to the “two signal
hypothesis,” which suggests that a protein requires two membrane localization signals to
associate to the plasma membrane.  Evidence in support of this principle is that G?t, whose
membrane signals are myristoylation and G?? binding, dissociates from the plasma
membrane upon GTP binding (120).
Proper protein localization is a necessary precursor to proper protein function.  As
evidence grows for protein translocation and re-localization in the course of signaling, it is
becoming increasingly clear that post-translational regulation is a key factor.  This regulation
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can take the shape of phosphorylation, ubiquitination, or reversible lipid-acylation, and much
of the work presented in this thesis will test the hypothesis that diverse combinations of
modifications may account for different subcellular localization of various G? subunits.
Here, we will review what is known for post-translational regulation of G?  subunits.
Because G? subunits vary so widely in the precise details of their regulation, we will focus
on the yeast G?i homolog, Gpa1.
Ubiquitination.  Ubiquitination is the covalent attachment of an 8.5 kilo-Dalton (kDa)
protein called ubiquitin (68).  This modification occurs on lysine residues and generally
marks a protein for degradation.  In the canonical method, the ubiquitin signal is actually that
of a poly-ubiquitin chain, which is added to the substrate protein through a three step process
involving a ubiquitin activating enzyme (E1), a ubiquitin conjugating enzyme (E2), and a
ubiquitin ligase (E3).  Substrate recognition generally occurs at the level of the E3, and there
are usually hundreds of E3’s in mammalian cells.  Poly-ubiquitination occurs either through
the sequential addition of 4 or more ubiquitin monomers to the substrate (creating a ubiquitin
chain) or the direct transfer of a poly-ubiquitin chain from the E2 to the substrate (with the
aid of an E3). In both cases, poly-ubiquitination typically results in the destruction of a
protein by the 26S proteasome.  Another, less common form of ubiquitination is mono-
ubiquitination.  As the name suggests, this differs from the canonical modification in that
only a single ubiquitin monomer is added to the substrate.  This modification was first
demonstrated to occur for histones, and later on the yeast pheromone receptor Sterile-2 (Ste2)
(71).  In this report, Hicke et al identified that Ste2 was mono-ubiquitinated in response to
stimulus and trafficked to the vacuole (the yeast lysosome) to be destroyed.  Although poly-
ubiquitination and Ste2 mono-ubiquitination both result in destruction, there is evidence for
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ubiquitin-mediated signal activation.  Work by James Chen and colleagues has uncovered
that poly-ubiquitination of TRAF6 is necessary for TAK1-TAB-TRAF6 complex formation,
IKK phosphorylation, and NF-kB signal activation (34).  The key observation of Chen’s
group was that ubiquitination of TRAF6 is through Lys-63 (on ubiquitin) rather than the
traditional Lys-48.  Other examples have since emerged—including work by Bill Tansey’s
group detailing the role of ubiquitination in transcriptional activation (127)—showing that
ubiquitination can be involved in signal activation as well as signal desensitization.
Gpa1 was recently found to be ubiquitinated (94, 98).  Marotti et al recognized that in
a proteasomal protease-deficient yeast strain, Gpa1 accumulated high molecular weight
species.  When separated using SDS-PAGE and probed for Gpa1, the characteristic poly-
ubiquitin associated “laddering” was visible.  Using a mass-spectrometry based approach,
they identified that Gpa1 is specifically ubiquitinated on K165.  The initial report did not
address the outcome of Gpa1-ubiquitination, so it remains to be seen whether this
modification is being used for protein turnover, or more directly for signaling.  Gpa1 was the
first G? known to be ubiquitinated, although there is also a report that G?s is modified by
ubiquitin (109).  Furthermore, alignments of G? subunits show sequence conservation of the
region around the ubiquitinated residue on Gpa1, including K165 (145).  Thus, it is possible
that other G? subunits are also modified in this manner.
Myristoylation.  Myristoylation is the addition of a saturated 14-carbon fatty acid
(C14:0) to a glycine residue at amino acid position two of the substrate protein (consensus
sequence is always M-G-X-X-X-(S/T)-X-X-X, with “M” being the translated ATG start
codon, which is subsequently cleaved off) (17).  Myristoylation is believed to be co-
translational and irreversible.  Myristoylation is also unique in that not all myristoylated
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proteins are membrane bound (Figure 1.3) (97).  This raises the possibility that myristate may
not simply be inserting into lipid bilayers, as is commonly thought (166).  Regardless of the
mechanism of action, myristoylation of G? subunits is known to promote their membrane
attachment (96).   In accordance with the “2 signal hypothesis” it has been found that the
hydrophobicity of myristate is not sufficient for stable association with the plasma
membrane.  The working theory in the field is that myristoylation of G? delivers the protein
to the plasma membrane where palmitoylation can occur (presumably because of the
existence of specifically localized protein acyl-transferases, or PATs).  Gpa1 is known to
exist as both myristoylated and unmyristoylated protein (144).  Myristoylation of Gpa1 is
regulated, in that it is increased upon pheromone treatment (40).  Given the understanding,
however, that the modification must be co-translational, it is likely pheromone-stimulated
myristoylation occurs during Gpa1 production, and not subsequently as a direct modification
of unmyristoylated protein.
Palmitoylation.  Palmitoylation is the attachment of the fatty acid palmitate (C16:0)
to a cysteine residue using a thioester bond (137).  Compared to myristoylation,
palmitoylation results in a much more stable association with lipid membranes and can occur
post-translationally; however, the mechanism by which palmitoylation occurs is not nearly as
well understood.  The first clues came from the lab of Bob Deschenes, who screened yeast
for genes involved in the palmitoylation of yeast Ras (11).  Shortly thereafter, Nick Davis’
group identified the yeast gene Akr1 as having a role in the palmitoylation of type I casein
kinases (52).  It quickly became apparent that Erf2 and Akr1 share a common element: a
conserved 50 residue, cysteine rich DHHC-CRD domain. To date, all identified PATs (only 7
have been identified to date) contain this DHHC motif (104).  Determining how
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palmitoylation occurs and identifying novel PATs is still an active area of research.  Many
G? subunits are palmitoylated, including Gpa1, although it is unknown which PATs are
responsible for this modification.
Signaling researchers have focused on palmitoylation because evidence exists to
suggest it is a reversible—and thus a regulatable—modification.  The first evidence for this
came from studies on G?s.  Various researchers found that the turnover of G?s palmitoylation
was dramatically accelerated by receptor activation.  Palmitate turnover on the inactive G
protein exhibited a half-life of approximately 90 minutes, however, ?-adrenergic receptor
activation resulted in palmitate turnover with a t1/2 of ~ 2 minutes (165).  Furthermore,
mutationally activated G protein exhibited a turnover rate similar to that of receptor activated
G protein (107). These data raise the possibility that depalmitoylation is involved in signal
desensitization or potentially in G protein translocation.   More evidence for this came from
Gilman and colleagues, who identified a family of conserved G?-specific de-palmitoylating
enzymes (45).  Although the in vitro biochemistry characterizing these enzymes is very
compelling, it is still unclear what role these proteins play in vivo.  One of these family
members, Apt1, exists in yeast (44), although it too has not been implicated in any G protein-
specific pathway.  Determining if Apt1 contributes to the regulation of Gpa1 will be
addressed in Chapter V of this thesis.
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Figure 1.3
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Figure 1.3  Potential roles of myristate. Like other lipid modifications,
myristoylation generally causes membrane association.  However, the hydophobicity
of myristate is below the threshold necessary for stable membrane binding, and there
is some question regarding the mechanism of myristate-dependent membrane
attachment.  Possible roles for myristoylation include (A) direct insertion into the lipid
bilayer, (B) direct interaction with a transmembrane protein, (C) myristate-dependent
protein-protein interaction, (D) myristate-dependent conformational change of the
substrate protein.
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THESIS SUMMARY
When research for this thesis began, intracellular signaling by G? subunits was just
beginning to be understood.  It had already been established that G? subunits existed at many
intracellular locations, but lacking was any evidence that these alternatively localized
proteins were relevant as signaling proteins.  Borrowing from the precedent set by other
signaling molecules— small GTPases, receptor and non-receptor tyrosine kinases—many,
including our group, began to address the function of G? subunits away from the plasma
membrane.   The major unanswered questions were very basic in nature:  do signals emanate
from non-plasma membrane sites?  How do G proteins traffick to various cellular locations?
How are intracellular G proteins activated?  Using the very basic yeast mating system, our
lab determined that the answer the first of these questions, finding that activated Gpa1 binds
to and activates an endosomal PI3K (136).  For my thesis research, I intended to answer the
latter two of the basic questions, specifically I set out too identify other activators of the yeast
mating pathway, and determining what signals Gpa1 uses to localize at the plasma membrane
and at intracellular locations.
The remainder of this thesis will be presented as four chapters.  In Chapter II,
“Determinants of Gpa1 poly- versus mono-ubiquitination,” I will present work performed by
myself as well as others from the Dohlman lab, in which we: 1) detail the discovery that
Gpa1 is both poly- and mono-ubiquitinated, 2) test the hypothesis that poly-ubiquitination is
reserved for misfolded protein, and 3) determine that myristoylation is necessary for Gpa1
mono-ubiquitination.  One of the critical components in this chapter is the creation and
validation of a mutant form of Gpa1 that is not myristoylated but nonetheless localizes
correctly to the plasma membrane.   In Chapter III, “Development of a Cell Viability Assay
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to Monitor Palmitoylation of Gpa1,” I will describe the creation of a novel mutant form of
Gpa1 that facilitates the screening of Gpa1 palmitoylation.  In addition, this chapter will
contain a validation of the screening method, as well as preliminary data detailing attempts to
determine how Gpa1 palmitoylation is regulated. In Chapter IV: “Identification and
characterization of a non-receptor exchange factor for yeast G? subunit, Gpa1,” I will
describe a screen directed at identifying candidate activators of Gpa1, as well as the
characterization of a novel GEF, Arr4.  Finally, in Chapter V, “Conclusions and Future
Directions,” I will discuss the big picture findings associated with this thesis, as well as
preliminary data associated with future directions for each of the chapters.
CHAPTER II
Determinants of Mono- versus Poly-Ubiquitination of Gpa1
Elements of the work referenced in this chapter has been published in:
Wang, Y. L.A. Marotti, M.J. Lee, H.G. Dohlman.  (2005) Differential regulation of G
protein alpha subunit trafficking by mono- and polyubiquitination.  J Biol Chem 280:
284-91
Figure contributed by:
Michael Lee: 2.1A; 2.2; 2.3C; 2.4A; 2.7-2.11
Matthew Torres: 2.5; 2.6; 2.12; 2.13
Yuqi Wang: 2.1B; 2.3A, B; 2.4B, C
Feng Ding: Table 2.1
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Summary
Previously we used mass spectrometry to show that the yeast G protein ? subunit
Gpa1 is ubiquitinated at Lys-165, located within a sub-domain not fully conserved with other
G? proteins.  Here we describe the functional role of Gpa1 ubiquitination.  We find that
Gpa1 is both mono- and poly-ubiquitinated. Proteasomal protease-defective rpt6/cim3
mutants accumulate poly-ubiquitinated Gpa1, and much of the protein exhibits cytoplasmic
localization.  In contrast, vacuolar protease pep4 mutants accumulate mono-ubiquitinated
Gpa1, and in this case the protein is localized within the vacuolar compartment. Cells that
lack Ubp12 ubiquitin-processing protease activity accumulate both mono- and poly-
ubiquitinated forms of Gpa1. In this case, Gpa1 accumulates in both the cytoplasm and
vacuole. All of these ubiquitin-mediated phenotypes are blocked by a Gpa1?128-236, a mutant
lacking the ubiquitinated sub-domain.  We show that poly-ubiquitination specifically clears
misfolded protein, whereas mono-ubiquitination regulates plasma membrane targeted, fully
mature Gpa1.  Mutations that decrease the fold stability of Gpa1 result in a corresponding
increase the poly-ubiquitination, but do not alter mono-ubiquitination.  Mutations that
decrease myristoylation but not plasma membrane targeting diminish mono-ubiquitination
but do not alter poly-ubiquitination, suggesting a direct role of myristate in the recognition of
Gpa1 by the mono-ubiquitination machinery.  Findings reported herein describe the
ubiquitin-mediated regulation of Gpa1, and provide evidence for multiple non-redundant
mechanisms for ubiquitin-mediated degradation.
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INTRODUCTION
Many sensory and chemical stimuli act via cell surface receptors and intracellular G
proteins. In yeast, G protein-coupled receptors initiate a signaling cascade that leads to
morphological changes, new gene transcription, cell cycle arrest, and eventually mating.
Mating, the process by which a and ? haploid cells fuse to form the a/? diploid, is initiated
by cell-type-specific peptide pheromones. Haploid a-type cells secrete a-factor pheromone,
which binds to specific receptors found only on ?-type cells, while ?-type cells secrete ?-
factor that acts exclusively on a-cells (41).
Most components of the pheromone-signaling cascade in yeast have been identified
through the isolation of gene mutations that produce an unresponsive sterile (ste) phenotype.
Genes required for mating include the receptors for ?-factor (STE2) and a-factor (STE3), the
G protein ? (STE4) and ? (STE18) subunits, G protein effectors (STE5, STE20, CDC24),
downstream protein kinases (STE20, STE11, STE7, FUS3, KSS1), as well as a transcription
factor (STE12). The G protein ? subunit serves primarily to regulate the levels of free G??.
Cells lacking the G? subunit gene (GPA1) cannot sequester G??, and so are permanently
activated (37, 105). The G? subunit can also modulate signaling through direct interaction
with the phosphatidyl-inositol-3-kinase (PI3K) Vps34 (136).
As with other G protein systems, pheromone binding to its receptor promotes the
exchange of GTP for GDP on the G? subunit, followed by dissociation of G? from the G??
subunit complex (38). The dissociated subunits in turn transmit and amplify the signal to
effector proteins that produce an intracellular response. Signaling persists until GTP is
hydrolyzed to GDP and the subunits reassemble. Given their position as intermediaries
between signal detectors (receptors) and signal transmitters (effectors), G proteins are well
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positioned to serve as targets of regulation. Particularly important in this role is the RGS
(“Regulator of G protein Signaling”) protein Sst2, which attenuates the pheromone signal by
accelerating Gpa1 GTP hydrolysis and thereby reducing the lifetime of the activated G
protein (4, 39).
There is growing evidence that G protein signaling components are also regulated by
post-translational modifications (24). Recent attention has focused on ubiquitination, the
process by which a ubiquitin polypeptide is covalently attached to specific target proteins
(117). The typical ubiquitin signal is actually comprised of a chain of four or more ubiquitin
monomers covalently linked through lysine-48.  Poly-ubiquitinated substrates are then
captured by the proteasome protease complex and rapidly degraded (159). Of the pheromone
signaling components in yeast, ubiquitination has been reported for the G? protein Gpa1 (94,
98), the RGS protein Sst2 (66), and the effector kinase Ste7 (162, 163). Ubiquitination of
both Ste7 and Sst2 are induced by pheromone, and these modifications are thought to
represent feedback loops leading to pheromone desensitization and resensitization,
respectively (66, 162, 163).
Ubiquitination has also been described for the pheromone receptors Ste2 and Ste3
(71, 123). However in this instance the proteins are mono-ubiquitinated instead of poly-
ubiquitinated, and degraded by the vacuole (the yeast counterpart to the lysosome) instead of
by the proteasome (33, 71, 123, 128). This discovery led to the hypothesis that ubiquitination
is primarily a protein trafficking signal, and mono-ubiquitination promotes degradation only
indirectly by allowing the substrate to undergo internalization and delivery to the vacuole
compartment (70).
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Recently we used mass spectrometry to identify the ubiquitination site of Gpa1 in
vivo (98). The site of modification (Lys-165) lies within the all-helical domain of the G
protein, and more specifically within a 110-residue sub-domain not fully conserved in other
G? subunits. Here we show that the Gpa1 sub-domain undergoes both mono- and poly-
ubiquitination: mono-ubiquitinated Gpa1 is targeted to the vacuole while poly-ubiquitinated
Gpa1 is delivered to the proteasome.  Furthermore, we demonstrate that Ubp12 is a ubiquitin-
processing enzyme that acts on both species of ubiquitinated Gpa1.  Finally, we demonstrate
that poly-ubiquitinated Gpa1 targets misfolded/unstable protein for destruction, whereas
mono-ubiquitinated Gpa1 is a trafficking signal for fully mature plasma membrane localized
Gpa1.  While testing the latter of these two hypotheses, we uncovered that myristoylation is
directly required for mono-ubiquitination of Gpa1.  Our findings show for the first time that a
single protein can be both mono- and poly-ubiquitinated, and we suggest a rationale for the
existence of two separate ubiquitination systems.
RESULTS
Gpa1 is both mono- and poly-ubiquitinated in yeast
Many cellular proteins are poly-ubiquitinated and degraded by the proteasome.
However, a handful of proteins are instead mono-ubiquitinated and delivered to the vacuole.
This alternative pathway was first documented for the yeast G protein-coupled receptors Ste2
and Ste3 (33, 71, 123). Both of these receptors are mono-ubiquitinated in response to
prolonged treatment with pheromone, and once modified they are rapidly endocytosed and
degraded within the vacuole compartment (71, 123, 128).  We and others have previously
found Gpa1 to be mono-ubiquitinated (94, 98), however, the possibility that Gpa1 could also
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be poly-ubiquitinated has never been addressed.  To test this possibility, we monitored Gpa1
expression in a temperature sensitive cim3-1 strain, a yeast strain deficient for proteasomal
activity (60) and pep4?, a strain deficient for vacuolar protease activity(126). Cim3 (also
known as Rpt6) is a subunit of the proteasome 19S regulatory particle, which confers
specificity for ubiquitinated proteins for presentation to the proteasome proteolytic subunits
(54), and Pep4, also known as Proteinase A, is a saccharopepsin aspartyl protease required
for activation of degradative enzymes within the vacuole. Gpa1 normally migrates as a
doublet of 54 kDa and 56 kDa (representing myristoylated and non-myristoylated species,
respectively) (40, 144). As shown in Figure 2.1 A, steady state levels of Gpa1 were ~2-fold
higher in the vacuolar protease-deficient pep4 mutant strain. Expression of Ste4 (G?) was
also elevated in these mutants. Surprisingly, however, Gpa1 (but not Ste4) expression was
also enriched in the cim3-1 mutant, suggesting that the G? protein can also be degraded by
the proteasome (Figure 2.1 A) (98). These findings suggest that Gpa1 can be degraded either
by the vacuole or the proteasome, while Ste4 is degraded primarily by the vacuole.
Whereas degradation by the proteasome typically requires substrate poly-
ubiquitination, vacuolar degradation of Ste2 is triggered by mono-ubiquitination (71). If
Gpa1 is degraded by the vacuole, defects in this pathway should result in an accumulation of
the mono-ubiquitinated form of the protein. Conversely, if Gpa1 is degraded by the
proteasome, defects in that pathway should result in an accumulation of poly-ubiquitinated
Gpa1. To test this we over-expressed Gpa1 in mutant strains deficient in either vacuolar
protease or proteasome activity. Over-expression was necessary for this experiment in order
to detect the minor ubiquitinated species. In wild-type cells, Gpa1 migrated at 54 and 56 kDa
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Figure 2.1  Gpa1 is poly- and mono-ubiquitinated in yeast. (A) Whole cell extracts were
prepared from a vacuolar protease mutant (pep4::KanMX), a temperature-sensitive
proteasomal protease defective mutant (cim3-1) grown at the restrictive temperature of 37 oC
for 4 h, and isogenic wild-type strains.  Samples were resolved by 7.5% SDS-PAGE and
detected by immunoblotting with antibodies against Gpa1 (G?), Ste4 (G?), or Pgk1 (loading
control), as indicated.  (B) left, A vacuolar protease-deficient (pep4::KanMX) mutant and the
isogenic wild-type strain were transformed with a plasmid containing wild-type GPA1
(pAD4M-GPA1). Plasmid-borne over-expression of Gpa1 was required in order to detect the
minor ubiquitinated species. Whole cell extracts were resolved by 7.5% SDS-PAGE and
immunoblotting with anti-Gpa1 antibodies. center, A proteasomal protease defective (cim3-
1) mutant and the isogenic wild-type strain were transformed with plasmid pAD4M-GPA1,
grown at the restrictive temperature of 37 oC for 4 h, and analyzed by immunoblotting with
anti-Gpa1 antibodies as described above. right, The same strains as in the left panel except
lacking the ?-factor receptor gene STE2.  Arrows indicate the mobility of unmodified Gpa1,
mono-ubiquitinated Gpa1 (“ubi-Gpa1”), and poly-ubiquitinated Gpa1 (“ubin-Gpa1”).
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It was shown previously that the pheromone receptor accumulates in the vacuole of
cells deficient in vacuolar protease activity (71, 128). To determine if Gpa1 is likewise
delivered to the vacuole we compared the distribution of the protein (expressed as a
chromosomally-integrated GFP fusion) in wild-type and pep4? mutant strains. As shown in
Figure 2.2, Gpa1 in wild-type cells was detected at the plasma membrane. In contrast, Gpa1
in the pep4? mutant was visible at the plasma membrane and also within the large vacuolar
compartment, which is easily identified as the most prominent organelle within the cell.
Taken together these data indicate that Gpa1, like Ste2, is mono-ubiquitinated and degraded
by the vacuole. Whereas the receptor is delivered to the vacuole upon pheromone
stimulation, the G protein is delivered in a constitutive or pheromone-independent manner.
Most cytoplasmic proteins are poly-ubiquitinated and delivered to the proteasome
complex. Thus we anticipated that poly-ubiquitinated Gpa1 would not be targeted to the
vacuole. To test this prediction we examined the subcellular distribution of Gpa1-GFP in the
proteasome-defective cim3-1 mutant strain, which accumulates the poly-ubiquitinated form
of the substrate. As shown in Figure 2.2, Gpa1 in the cim3-1 mutant was predominantly
localized in the cytoplasm, and in contrast to pep4? was largely excluded from the vacuole.
We presume that the cytoplasmic staining represents Gpa1 associated with, or en route to, the
proteasome complex. Taken together these data suggest that Gpa1 is delivered to the
proteasome when poly-ubiquitinated but not when mono-ubiquitinated.  Conversely, Gpa1 is
delivered to the vacuole when mono-ubiquitinated but not when poly-ubiquitinated.
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Wild type pep4∆ cim3-1
Figure 2.2
Figure 2.2  Ubiquitin-dependent trafficking of Gpa1. Vacuolar protease-deficient
(pep4::KanMX), proteasomal protease-deficient (cim3-1), and the isogenic wild-type
strains were transformed with an integrating plasmid (pRS406-GPA1-GFP) containing
the native GPA1 promoter and gene fused to the gene encoding yeast-enhanced green
fluorescent protein. Cells were grown to mid-log phase at 30o C and visualized by DIC
and fluorescence microscopy. Cells expressing Gpa1 alone exhibited negligible
background autofluorescence (data not shown).
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Ubp12 is a ubiquitin-processing protease for Gpa1
We next aimed to determine how Gpa1 ubiquitination was regulated.  Yeast have 16
ubiquitin-processing proteases (UBPs), otherwise known as de-ubiquitinating enzymes
(DUBs), or ubiquitin-specific proteases (USPs). By screening mutants that lack each of 16
UBPs we previously had found one (ubp3?) that resulted in the accumulation of poly-
ubiquitinated Ste7 (162, 163). We conducted a similar screen of the UBP deletion mutants
and found another, ubp12?, that specifically accumulated ubiquitinated Gpa1 (Figure 2.3 A
and data not shown). Moreover, immunoprecipitation of Ubp12 resulted in the co-
purification of Gpa1, further suggesting that Gpa1 ubiquitination is regulated directly by
Ubp12 (Figure 2.3 B).  To further corroborate these results, we also monitored Gpa1
expression and localization in the ubp12? background.  To facilitate detection of ubiquitin
(mono-ubiquitin in particular) we also over-expressed myc-tagged ubiquitin under the control
of a copper-inducible promoter.  Consistent with our previous observations, we found that
the ubp12? caused accumulation of both mono-and poly-ubiquitinated Gpa1 (Figure 2.3 C).
Also, in ubp12? cells—under conditions where Gpa1 is poly-ubiquitinated and mono-
ubiquitinated in the same cell—the protein is directed to both the vacuolar compartment and
the cytoplasm.  Stated differently, the distribution of Gpa1 in this case is an amalgamation of
the distribution seen in pep4? and cim3-1 cells.
Deletion of the ubiquitinated sub-domain eliminates Gpa1 ubiquitination
We then wished to determine the fate of Gpa1 that is not ubiquitinated. Initially we
examined the localization of Gpa1K165R, which lacks the primary site of in vivo ubiquitination
(98). However we found the subcellular distribution of Gpa1K165R was similar to that of the
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Figure 2.3  Regulation of Gpa1 by Ubp12. (A) A ubiquitin-processing protease deficient
(ubp12::KanMX) mutant and isogenic wild-type strain were co-transformed with plasmids
containing Gpa1 (pAD4M-GPA1) and Myc-ubiquitin under the control of the copper-
inducible CUP1 promoter (pND747). Mid-log phase cells were treated with 100 µM CuSO4
for 4 h, as indicated, and then collected and resolved by 7.5% SDS-PAGE and
immunoblotting using anti-Gpa1 antibodies. Arrows indicate the mobility of unmodified
Gpa1, as well as the mono-ubiquitinated (“ubi-Gpa1”) and poly-ubiquitinated (“ubin-Gpa1”)
species. (B) Wild-type cells were co-transformed with plasmids containing Gpa1 (pAD4M-
GPA1) and Flag-epitope-tagged Ubp12 (pYES-UBP12-Flag) or the empty parent vector.
Flag-Ubp12 was immunoprecipitated (“IP”) with M2 anti-Flag resin and the copurification of
Gpa1 with Ubp12 was detected by immunoblotting (“IB”) with anti-Gpa1 and anti-Flag
antibodies, respectively.  An immunoblot of whole cell extracts (“WCE”) is also shown to
confirm equal expression of Gpa1. (C) A ubiquitin-processing protease deficient
(ubp12::KanMX) mutant and isogenic wild-type strain were transformed with an integrating
plasmid (pRS406-GPA1-GFP) encoding Gpa1 fused to GFP and a plasmid containing Myc-
ubiquitin under the control of the copper-inducible CUP1 promoter (pND747). Cells were
treated with CuSO4 for 4 h and visualized at mid-log phase by DIC and fluorescence
microscopy. Cells expressing Gpa1 alone exhibited negligible background autofluorescence
(data not shown).
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(Figure 2.1 B). In the vacuolar-protease deficient pep4? strain an additional mono-
ubiquitinated species migrated near 63 kDa (Figure 2.1 B, left) (94, 98). In contrast, the
proteasome-deficient cim3-1 strain accumulated a ladder of high molecular weight bands
representing poly-ubiquitinated Gpa1 (Figure 2.1 B, center) (94, 98). These results support
the suggestion that Gpa1 is degraded by two routes; one entails mono-ubiquitination and
delivery to the vacuole while the second requires poly-ubiquitination and delivery to the
proteasome.
Mono-ubiquitinated Gpa1 trafficks to the vacuole, whereas poly-ubiquitinated Gpa1 is
degraded by the proteasome
The vacuolar degradation pathway is used turnover of the pheromone receptor and, as
shown here, the G protein ? subunit Gpa1. Mono-ubiquitination of the receptor is enhanced
by pheromone. Since the receptor and G protein bind to one another, we investigated whether
mono-ubiquitination and/or degradation of both substrates occur in a coordinated manner.
We first examined whether mono-ubiquitination of Gpa1 was affected by prolonged
exposure to pheromone, and consistently found no difference (data not shown) (98). Second,
we tested whether mono-ubiquitination of Gpa1 was affected by deletion of the receptor gene
STE2, and again found no difference (compare pep4? and ste2?/pep4? mutants, Figure 2.1
B, right). These data indicate that Gpa1 mono-ubiquitination as well as vacuolar sorting
occurs independently of receptor binding or pheromone occupancy.
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wild-type protein (data not shown). We presume that one or more secondary sites are
modified when Lys-165 is altered, and this accounts for the residual ubiquitination as well as
the unaltered subcellular localization of the mutant protein. We also reasoned that any
secondary sites are likely to be clustered within the same 110-residue sub-domain that
contains Lys-165. To test this possibility we constructed and analyzed a mutant form of the
protein that lacks the ubiquitinated sub-domain altogether (Gpa1?128-236). The position of the
internal deletion was chosen based on a sequence alignment of Gpa1 with G?i and G?t, two
mammalian proteins that lack the sub-domain and for which crystal structures are available
(16, 141). We first compared the ubiquitination of wild type Gpa1 and Gpa1?128-236. Using a
Gpa1-specific antibody (as in Figure 2.1 B) we found that Gpa1?128-236 was neither mono- nor
poly-ubiquitinated (data not shown).  These results suggest that ubiquitination is largely
blocked by deletion of the 110 residue sub-domain in Gpa1.
Since either mono- or poly-ubiquitination promotes a redistribution of Gpa1 away
from the plasma membrane, the absence of ubiquitination would most likely favor Gpa1
localization to the plasma membrane.  Indeed, Gpa1?128-236 was present almost exclusively at
the plasma membrane even when expressed in the protease-deficient pep4? and ubp12?
mutants (Figure 2.4 A).  Since removal of the ubiquitinated sub-domain results in increased
localization to the plasma membrane, we then asked whether Gpa1?128-236 diminishes G??-
mediated signaling.  Over-expression of Gpa1 is known to cause slight signal inhibition,
because more G? exists to sequester G??.  Initially we measured pheromone sensitivity using
a standard growth arrest assay.  In this method a nascent lawn of cells is exposed to a point
source of ?-factor.  As the lawn develops a zone of growth inhibition appears, the size of
which reflects the sensitivity of the cells to pheromone-induced growth arrest.  As shown in
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Figure 2.4  Blocking Gpa1 ubiquitination enhances plasma membrane localization and
Gpa1 function.  (A) A pep4? or ubp12? strain was transformed with an integrating plasmid
encoding Gpa1 fused to GFP (pRS406-GPA1-GFP) or the corresponding mutant lacking the
ubiquitination sub-domain (pRS406-GPA1?128-236-GFP). Cells were grown to mid-log phase
and visualized by DIC and fluorescence microscopy. Cells expressing Gpa1 alone exhibited
negligible background autofluorescence (data not shown). (B) and (C) Strain YGS5
(gpa1? stellts) was transformed with a single-copy plasmid (pRS316) containing either the
wild-type GPA1 promoter and gene (“Gpa1”) or a mutant lacking the ubiquitination sub-
domain (“Gpa1?128-236”), as well as a plasmid (pRS425-FUS1-lacZ) containing the
pheromone-induced FUS1 promoter and lacZ reporter. (B) Cells were plated onto solid
medium and exposed to paper discs containing ?-factor pheromone (clockwise from bottom
right: 1, 5, 15, and 45 µg) for 48 h. (C) Cells in mid-log phase of growth were treated with
the indicated concentrations of ?-factor, and the resulting ?-galactosidase activity was
measured spectrofluorimetrically. Data shown are representative of three independent
experiments performed in triplicate. Error bars, ± SEM.
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Figure 2.4 B, cells expressing Gpa1?128-236 exhibited a smaller and more turbid zone of
growth inhibition compared with the wild-type protein, indicating a diminished pheromone
response.  We also compared Gpa1?128-236 and Gpa1 activity using a reporter-transcription
assay consisting of the pheromone-inducible FUS1 promoter driving expression of lacZ (?-
galactosidase) (74). As shown in Figure 2.4 C, cells expressing Gpa1?128-236 exhibited a
~30% reduction in the maximum pheromone response, consistent with the reduced growth
arrest response described above. Thus deletion of the ubiquitination sub-domain appears to
enhance the ability of Gpa1 to block the G??-mediated signal, resulting in diminished growth
arrest and transcription-induction responses. Taken together, these data suggest that
intracellular targeting of Gpa1 depends on the extent of ubiquitination. Whereas non-
ubiquitinated Gpa1 is retained at the plasma membrane, mono-ubiquitinated Gpa1 is
delivered to the vacuole and poly-ubiquitinated Gpa1 is delivered to the proteasome.
Decreasing the fold stability of Gpa1 increases poly- but not mono-ubiquitination of
Gpa1
Here, we’ve found that Gpa1 is targeted for degradation by mono- and poly-
ubiquitination, both of which affect Gpa1 steady state levels in vivo as well as pheromone-
dependent signaling in yeast. One possible explanation for the existence of two separate
ubiquitin-mediated degradation mechanisms is that mono- and poly-ubiquitination are non-
redundant protein degradation signals that target distinct cellular pools of Gpa1:  where poly-
ubiquitination signals the degradation of Gpa1 that is structurally unstable or misfolded, and
mono-ubiquitination signals the degradation of properly folded Gpa1 as part of a regulated
protein-clearing mechanism. Indeed it has been estimated that as much as 30% of newly
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synthesized proteins are incorrectly made and quickly degraded (130). To test this
hypothesis, we used the protein modeling software Medusa to identify point mutations in the
known crystal structure of human G?i (PDB code: 1AGR) that were conserved in yeast and
predicted to create a gradient of protein fold stabilities relative to the wild type protein (Table
2.1) (PMID 16839198).  Benchmarked on a large set of experimentally characterized
mutations, Medusa has been used to recapitulate changes in the structural stability of proteins
upon amino acid substitution, and to do so with high accuracy (PMID 18073107; PMID
17538626).  Five point mutations (F383A, F369A, L385A, V340A, and F406A) were
selected that were predicted not to interfere with the catalytic, switch, or RGS binding
regions of Gpa1 so as to avoid altering protein function.  To evaluate their effect on Gpa1
poly-ubiquitination, each mutation was introduced separately into GPA1 contained on high
expression vector (pAD4M), and expressed in yeast harboring the cim3-1 temperature
sensitive mutation or an isogenic wild type strain.  As shown in Figure 2.5, Gpa1 poly-
ubiquitination appeared as a ladder of high molecular weight western blot bands visible in
extracts prepared from the cim3-1 strains but not from the isogenic wild type strain (Figure
2.5 A, left two lanes).  Laddering was not observed in extracts from cells transformed with
empty vector, indicating that the high molecular weight western blot signal was specific to
Gpa1 (data not shown).  In addition, poly-ubiquitination increased in proportion to the
predicted destabilization for each Gpa1 point mutation.  These data suggest that misfolded
Gpa1 is recognized by the poly-ubiquitination machinery (Figure 2.5 A, C).
We next asked if destabilization alters mono-ubiquitination. We expressed each of the
Gpa1 destabilizing point mutants in pep4? cells or the isogenic wild type strain and
conducted western blot analyses of whole cell extracts using anti-Gpa1 antibodies.
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Table 2.1
Table 2.1 Relative free energies of Gpa1 protein fold-destabilizing mutations.
Medusa protein modeling software was used in combination with the high resolution
crystal structure of human Gαi (PDB code: 1agr) to identify a set of five point
mutations that are conserved in the yeast G alpha protein Gpa1 and predicted to create
a gradient of protein fold stabilities relative to the wild type protein (see methods).
The structural stability of the mutant protein is computed using the relaxed structure
and the mutation-induced stability change (∆∆G) is obtained by subtracting the wild
type stability.  Mutations with higher ∆∆G values are predicted to create the greatest
negative effect on protein fold stability.
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Figure 2.5
Figure 2.5  Gpa1 polyubiquitination, but not monoubiquitination, increases with
increasing fold destabilization of Gpa1. (A) A proteosomal protease defective
mutant (cim3-1) and the isogenic wild type strain were transformed with plasmid
pAD4M-GPA1 (WT) or the indicated point mutant, grown at the restrictive
temperature of 37°C for 5 hours.  Whole cell extracts were resolved by 10% SDS-
PAGE and immunoblotting with anti-Gpa1 antibodies. (B) A vacuolar protease-
deficient (pep4∆) mutant and the isogenic wild type strain were transformed with
plasmid pAD4M-GPA1 or the indicated point mutant and grown to mid-log phase at
30°C.  Whole cell extracts were examined as described above. The difference in film
exposures between cim3-1 and pep4∆ experiments is required to ensure visualization
of either the monoubiquitin band (which is in close proximity to the Gpa1 bands) or
polyubiquitin laddering.  (C) Densitometry of polyubiquitin laddering (from A) or the
monoubiquitin band (from B) of Gpa1 relative to the wild type protein expressed in
the cim3-1 or pep4∆ strain, respectively.
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The presence of Gpa1 mono-ubiquitination was evident as a single band at ~63 kDa that was
enhanced in the pep4? strains (Figure 2.5 B, first two lanes).  In contrast to Gpa1 poly-
ubiquitination, Gpa1 mono-ubiquitination did not change with respect to the predicted
increase in protein fold destabilization (Figure 2.5 B, C).  We determined that the lack of
mono-ubiquitination of the Gpa1 mutants was not due to gross mutation-dependent
functional defects in Gpa1, since Gpa1 mutant isoforms complemented a gpa1? mutation,
responded normally to pheromone in both halo growth arrest and FUS1-lacZ transcriptional
assays, and exhibited no difference in steady state levels when expressed from the native
GPA1  promoter (data not shown).  Taken together, these data indicate that poly-
ubiquitination, but not mono-ubiquitination, is used to signal the degradation of misfolded
Gpa1 in vivo.
Mono-ubiquitination of Gpa1 requires Gpa1 myristoylation
Poly-ubiquitination and proteasomal degradation of proteins occurs primarily in
cytoplasmic, nuclear, and rough endoplasmic reticulum regions of the cell (18, 19, 48), and is
a principal mechanism for the elimination of misfolded proteins in vivo (130).  In contrast,
mono-ubiquitination has been shown to serve as an endocytosis signal that initiates
trafficking of plasma membrane-bound proteins such as Ste2 and Ste3 to the vacuole, where
they are degraded (71, 123, 128).  Since Gpa1 simultaneously exists as two different lipid
modified isoforms at two different locations—an N-myristoylated form at the plasma
membrane and a non-myristoylated form that is incapable of localizing to the plasma
membrane—we investigated whether mono-ubiquitination was specific for the plasma
membrane targeted for of Gpa1.  We compared mono-ubiquitination (in pep4? cells) or poly-
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ubiquitination (in cim3-1 cells) of three specific forms of Gpa1: wild-type Gpa1 (plasma
membrane and non-plasma membrane), Gpa1G2A (only non-plasma membrane), Gpa1S200A
(only plasma membrane).  Gpa1G2A cannot be myristoylated and is localized in the
cytoplasm, yet still retains wild type GDP-dependent binding affinity for G??  (139).
Gpa1S200A is a point mutant of the Serine-200 phosphorylation site (89), which we found
exists only in the myristoylated state (Figure 2.6 A) (155).  We determined that the S200A
mutation did not significantly alter Gpa1 function as cells transformed with the mutant
exhibited wild type plasma membrane association and pheromone responsiveness as
determined by fluorescence microscopy and a halo growth arrest assay, respectively (Figure
2.6 B).  We found that Gpa1S200A was mono- and poly-ubiquitinated to the same degree as
wild type Gpa1 (Figure 2.6 C).  In contrast, mono-ubiquitination was undetectable for the
unmyristoylated Gpa1G2A and poly-ubiquitination was significantly reduced but not absent
compared to wild type Gpa1 (Figure 2.6 D).  These data suggest that plasma membrane
localization and/or N-myristoylation of Gpa1 is required for its mono-ubiquitination and
critical, although not required, for poly-ubiquitination of Gpa1.
Membrane localization alone is not sufficient to restore mono-
Having determined that mono-ubiquitination occurs only if Gpa1 is properly
myristoylated and plasma membrane targeted, we next questioned whether the lack of mono-
ubiquitination resulted simply from mislocalization or directly from the lack of
myristoylation of the Gpa1G2A mutant.  In order to separate membrane attachment from other
possible functions of myristate, we created a mutant form of Gpa1 that was not myristoylated
but nevertheless properly localized at the plasma membrane.
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Figure 2.6
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Figure 2.6  N-myristoylation is critical for polyubiquitination but required for
monoubiquitination of Gpa1. (A) Anti-Gpa1 western blot of BY4741 yeast expressing
pAD4M-GPA1 or the indicated point mutant. (B) DIC and fluorescence microscopy images
of BY4741 yeast transformed with an integrating plasmid (pRS406-GPA1-GFP) containing
the native GPA1 promoter and either the native or a S200A mutant open reading frame fused
to the gene encoding yeast-enhanced green fluorescent protein (GFP) (left panel). Strain
ste7? gpa1? was transformed with single copy plasmids pRS315-STE7 and either pRS316-
GPA1 (WT) or pRS316-GPA1S200A (S200A), with each gene under the control of its native
promoter.  Transformed cells were plated onto solid medium and exposed to paper discs
containing ?-factor pheromone (clockwise from top:  1.5, 4.5, 15, and 45 µg)  (right panel).
(C) pAD4M-gpa1S200A was expressed in either cim3-1, pep4?, or the corresponding isogenic
wild type strains and analyzed by western blotting with anti-Gpa1 antibodies as described in
Figure 2.5.  Note that all lanes shown within a single panel are from a single gel. (D)
pAD4M-gpa1G2A was expressed in either cim3-1, pep4?, or the corresponding isogenic wild
type strains and analyzed by western blotting with anti-Gpa1 antibodies as described in
Figure 2.5.  Note that all lanes shown within a single panel are from a single gel.
Polyubiquitinated Gpa1 (Gpa1-(Ub)n), monoubiquitinated Gpa1 (Gpa1-Ub), and
myristoylated Gpa1 (Gpa1myr) are indicated.
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Figure 2.7
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Figure 2.7  Gpa1
G2A/4K
 rescues inviability of the unmyristoylated mutant.  (A) Sequence
alignments of Gpa1 myristoylation and poly-basic mutants (shown are the first 14 amino
acids) (B) ste7? gpa1? cells were transformed with pRS315-STE7 and pRS316-GPA1 or the
4K mutant.  Top Cell extracts were resolved using 7.5% SDS-PAGE, and immunoblotting
using anti-Gpa1 antibody. Bottom Cells were grown to mid-log phase, treated with 3 µM ?
mating factor, and aliquots removed at timed intervals.  Cell extracts were resolved using
12% SDS-PAGE and immunoblotting using anti-phospho-p44/42 MAPK antibody. (C)
YGS5 strain was transformed with pRS316-GPA1 or the indicated mutant.  Cells were grown
to saturation, and 3 µl saturated culture was spotted in serial 2-fold dilutions onto selective
media agar plates.
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Our method in creating such a mutant was inspired from findings by Deschenes and
others that a poly-basic stretch of amino acids can substitute for lipid-acylation and restore
membrane localization (103). Gpa1 is known to contain two N-terminal lipid-
modifications—a myristoylated Gly at position 2, and a palmitoylated Cys at position 3—and
we designed the poly-basic stretch to be close to the N-terminus near
myristoylation/palmitoylation sites. The resulting mutant will from here forward be referred
to as Gpa1G2A/4K, indicating that it lacks the ability to be myristoylated contains 4 Lys
residues at amino acid positions 7-10 in place of a Thr-Gln-Thr-Ile (Figure 2.7 A). We found
that the 4 lysine residues were not disruptive to protein stability or protein function., given
that Gpa14K (which can be myristoylated but also has the poly-lysine stretch) was expressed
at similar levels to wild-type Gpa1 and was still capable of regulating pheromone-dependent
phosphorylation of downstream MAPKs (Figure 2.7 B).  Thus, replacing residues 7-10 with
lysines does not appear to hamper Gpa1 function.
Cells that express unmyristoylated Gpa1G2A as the only form of Gpa1 are not viable,
as Gpa1 cannot localize to the plasma membrane, and Ste4 signals constitutively resulting in
growth arrest.  To determine if Gpa1G2A/4K could rescue the inviability associated with
unmyristoylated Gpa1, we expressed Gpa1G2A and Gpa1G2A/4K in the YGS5 strain (gpa1?
ste11
ts).  Serial dilutions show that Gpa1G2A/4K, but not Gpa1G2A, conferred viability in
signaling-competent cells (Figure 2.7 C).  At the permissive temperature where signaling is
restricted, cells expressing Gpa1G2A and Gpa1G2A/4K were equally viable.  Thus, the addition
of the poly-lysine stretch rescued the inviability of the Gpa1G2A mutation.
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Figure 2.8  Gpa1
G2A/4K
 is localized to the plasma membrane. ste7? gpa1?  strains were
transformed with an integrating plasmid (pRS406-GPA1-GFP, or indicated mutant in the
same plasmid) containing the native GPA1 promoter and gene fused to the gene encoding
yeast-enhanced green fluorescent protein. Cells were grown to mid-log phase at 30 oC and
visualized by DIC and fluorescence microscopy. Cells expressing Gpa1 alone exhibited
negligible background autofluorescence (data not shown).
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0
50
100
150
-5 -4 -3 -2 -1 0 1 2
0
5000
10000
15000
20000
25000
Vector
GPA1G2A/4K
GPA1
log10 [alpha factor] mM
A
B
Figure 2.9  Gpa1G2A/4K retains wild-type signaling function when over-expressed.
BY4741 strain was transformed with a high copy plasmid (pAD4M) containing either
the wild-type GPA1 or indicated mutants, as well as a plasmid (pRS425-FUS1-lacZ)
containing the pheromone-induced FUS1 promoter and lacZ reporter. Cells in mid-log
phase of growth were treated with the indicated concentrations of α-factor, and the
resulting b-galactosidase activity was measured spectrofluorimetrically. Data shown
are representative of three independent experiments performed in triplicate. Error bars,
± SEM. (A) Basal activity (B) pheromone-induced activity.
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We next wanted to determine if the restored viability was due to proper localization at
the plasma membrane.  To answer this question, we created a GFP-tagged version of
Gpa1G2A/4K and monitored the localization of this protein in live cells using fluorescent
microscopy.  We found that Gpa1G2A/4K-GFP localized to the plasma membrane, as did wild-
type Gpa1-GFP.  In contrast, Gpa1G2A-GFP localized diffusely throughout the cytoplasm
(Figure 2.8).  Quantization of the fluorescence revealed that the membrane localization of the
G2A/4K mutant was similar to that of wild-type Gpa1 (data not shown).
Although Gpa1G2A/4K is localized correctly at the plasma membrane, it remained a
possibility that the mutant was not a functional signaling protein.  To determine whether
Gpa1G2A/4K was competent to signal, first we tested the effect of Gpa1 over-expression on the
expression of the FUS1-LacZ transcription reporter.  Over-expression of wild-type Gpa1
causes dampening of both basal and pheromone-induced pathway activation, by providing
more Gpa1 to sequester free G?? at the plasma membrane.  We found that over-expression of
Gpa1G2A/4K dampened basal pathway activation similarly to over-expression of wild-type
Gpa1 (Figure 2.9 A).  Over-expression of Gpa1G2A had no effect, relative to empty vector,
consistent with its inability to target the plasma membrane and sequester G??.  Similar
results were seen for pheromone-induced transcriptional activation (Figure 2.9 B).
As another measure of signaling competence, we also monitored sensitivity to
pheromone using the standard growth arrest assay. When compared to cells expressing wild-
type Gpa1, Gpa1G2A expressing cells were not viable (data not shown), however, the addition
of the poly-lysine stretch restored the ability to regulate pheromone signaling (Figure 2.10).
To be certain that the poly-lysine stretch itself was responsible for restoring the signaling lost
in the Gpa1G2A mutant, we also created a series of mutants containing varied lysine stretches
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(1K, 2K, 5K, and 6K, in addition to 4K).  We found that pheromone sensitivity was inversely
proportional to the basic nature of the poly-lysine stretch, with the least basic (1K) being the
most sensitive, and the most basic (6K) being the least sensitive (Figure 2.10).  We noticed
that 6K cells were almost indistinguishable from wild-type, whereas 4K cells were slightly
super-sensitive to pheromone.  For further analysis, however, we decided to use 4K cells
because: 1) we desired to keep mutations to a minimum considering that the N-terminal
region is involved in other critical functions such as G?? binding, and 2) the addition of 4K
fully rescued plasma membrane localization of Gpa1G2A, suggesting the gain of function
provided by 6K was not mediated by increased membrane localization. These functional data
suggest that poly-lysine Gpa1 is able to restore localization and signaling in the absence of
myristoylation.
We were also interested in determining if Gpa1G2A/4K was modified correctly.  The
wild-type G protein is known to be palmitoylated in addition to being myristoylated, and
palmitoylation is also known to be dependent on myristoylation (96). It is believed that this is
true simply because myristoylation delivers Gpa1 to the plasma membrane, where
palmitoylation likely occurs (46).  Thus, we anticipated that Gpa1G2A/4K should also be
correctly palmitoylated.   Loss of palmitoylation is known to cause increased sensitivity to
pheromone, which can be measured using the pheromone-induced growth arrest assay
(Figure 2.11 A).  We found that Gpa1G2A/C3S/4K—the unmyristoylated, unpalmitoylated, poly-
lysine containing mutant of Gpa1—showed a 15% increase in the zone of pheromone
induced growth inhibition when compared to Gpa1G2A/4K (Figure 2.11 B).  The magnitude of
the increased sensitivity was equal to that seen when the C3S mutation is added to Gpa1.
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Figure 2.10  Pheromone-sensitivity of unmyristoylated Gpa1 is recovered by the
addition of a poly-basic stretch.  ste7? gpa1? strain was transformed with pRS315-STE7
and pRS316-GPA1, or the indicated mutant. Cells were grown to saturation overnight in
selective media, plated onto solid medium, and exposed to paper discs containing ?-factor
pheromone (clockwise from right: 1, 5, 15, and 45 µg) for 48 h.
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These data suggest that in the absence of myristoylation, restoring membrane localization
using Gpa1G2A/4K is sufficient to restore Gpa1 palmitoylation. Taken together, these assays
for cell viability, protein localization, and G protein signaling confirm that Gpa1G2A/4K is a
functional, properly localized, but not myristoylated form of Gpa1.
We then determined if localization to the plasma membrane was sufficient to restore
mono-ubiquitination of unmyristoylated G protein.  We found that mono-ubiquitination of
Gpa1G2A/4K was undetectable in comparison to Gpa1 in pep4? and in wild type cells (Figure
2.12 A). Since mono-ubiquitination was observed for Gpa14K, which contains Gly-2 and is
myristoylated, we conclude that the lack of mono-ubiquitination of Gpa1G2A/4K was not
caused by the poly-basic stretch.  When we analyzed the same Gpa1 mutants in the cim3-1
strain, we found that poly-ubiquitination of Gpa1G2A/4K was slightly elevated relative to
Gpa1G2A, yet not to the same level as wild type Gpa1 (Figure 3.12 B, right panel). Taken
together, these data suggest that N-myristoylation itself, and not plasma membrane
localization, is required for Gpa1 monoubiquitination.
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Figure 2.11  Poly-basic Gpa1 mutants require the palmitoylated Cys residue for full
sensitivity to pheromone.  (A) Performed as in Figure 2.10.  (B) Diameter of growth
restriction was measured for 4 different alpha factor concentrations on 3 different plates.
Data are mean ± SEM.
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Figure 2.12
Figure 2.12  Establishing plasma membrane localization of Gpa1G2A through an
N-terminal polybasic stretch does not re-establish Gpa1 monoubiquitination. (A)
pAD4M-GPA1 (WT) or the indicated point mutant were expressed in pep4∆ or the
corresponding isogenic wild type strain and analyzed by western blotting with anti-
Gpa1 antibodies as described in figure 2.1  ( B  )pAD4M-GPA1 (WT) or the indicated
point mutant were expressed in cim3-1 or the corresponding isogenic wild type strain
and analyzed by western blotting with anti-Gpa1 antibodies as described in Figure 2.5.
Polyubiquitinated Gpa1 (Gpa1-(Ub)n) and monoubiquitinated Gpa1 (Gpa1-Ub) are
indicated.
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DISCUSSION
Two modes of ubiquitin-mediated destruction of Gpa1
Ubiquitination is a well-known trafficking/degradation signal.  Many proteins are
poly-ubiquitinated and destroyed by the proteasome, while others are mono-ubiquitinated
and typically trafficked to the lysosome/vacuole.  In an effort to characterize the
ubiquitination of Gpa1, we found that Gpa1 can be both mono- and poly-ubiquitinated:
mono-ubiquitinated Gpa1 is trafficked to the vacuole and poly-ubiquitinated Gpa1 is
trafficked to the proteasome.  These results further validate the hypothesis that ubiquitination
is a trafficking signal first, and a degradation signal second (70). We found that the two
modes of Gpa1 ubiquitination are not redundant:  poly-ubiquitin-mediated degradation
appears to regulate misfolded protein, whereas mono-ubiquitin-mediated degradation
regulates the turnover of functional Gpa1.  These data provide an explanation as to why two
forms of ubiquitination exist for a single protein.
Our analysis benefited greatly from several unique features of the experimental
system. First, our previous mass spectrometry analysis had revealed that Gpa1 is
ubiquitinated at Lys-165 in vivo (98). This allowed us to design a mutant form of Gpa1
(Gpa1?128-236) that does not undergo ubiquitination. Another important advantage was the
available crystal structure of mammalian G?t and G?i proteins, which closely resemble yeast
Gpa1 in both sequence and function (16, 141). Thus our destabilizing mutants and Gpa1?128-
236 mutant could be designed in a rational manner based on the predicted folded structure of
the protein, without altering known sites of GTP binding, subunit interaction, receptor
coupling, or membrane association.
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Figure 2.13  Gpa1 mono- and poly-ubiquitination requires N-myristoylation.
Data presented herein suggest that N-myristoylation is necessary for Gpa1
ubiquitination.  Shown here is a simple model depicting the relationship between
phosphorylation, myristoylation and ubiquitination of Gpa1.
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Another interesting finding in this study is that mono-ubiquitination of Gpa1 requires
Gpa1 myristoylation, but not simply plasma membrane localization.  This finding required
the creation of Gpa1G2A/4K, a mutant form of Gpa1 that is localized correctly but not
myristoylated, and also Gpa1S200A, a mutant that is fully myristoylated.  Here, we presented
validation that the G2A/4K mutant was properly localized, competent to transmit pheromone
signals, and correctly modified by palmitate.
Another unique feature of our experimental system is the ability to manipulate the
extent of ubiquitination, through the use of mutants that selectively stabilize mono- or poly-
ubiquitinated substrates. Myc-ubiquitinated proteins are poor substrates for proteolysis and
therefore accumulate to higher-than-normal levels within the cell (47). pep4 mutants disrupt
vacuolar protease function, and have been successfully used to enrich mono-ubiquitinated
substrates (71, 123, 126). cim3 mutants disable proteasome protease activity and therefore
result in the accumulation of poly-ubiquitinated substrates (28, 29, 60, 98, 162). Although
less commonly applied, ubp mutants can also be very effective in preserving short-lived
changes in protein ubiquitination. This approach is analogous to using specific phosphatase
inhibitors to preserve transient increases in protein phosphorylation.
Potential contribution to intracellular signaling
Of the pheromone signaling proteins shown to undergo ubiquitination, nearly all are
modified in response to pheromone treatment. Documented examples include the pheromone
receptors Ste2 and Ste3, the RGS protein Sst2, and the effector MAP kinase kinase Ste7. In
contrast, Gpa1 is ubiquitinated in a constitutive manner, independent of pheromone
stimulation, thus it seems unlikely that the purpose of Gpa1 mono-ubiquitination is signal
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desensitization.  It is not clear why constitutive ubiquitination would be beneficial, however,
one possibility is that the true function of Gpa1 ubiquitination is to create a steady state
population of internalized Gpa1.  We have previously shown that Gpa1 regulates the
endosomal PI3K Vps34, however, we have not determined the modification status of
endosomal Gpa1.  Considering that mono-ubiquitinated Gpa1 must traffick through
endosomes before arriving at the vacuole, it is possible that the function of mono-
ubiquitination is to localize Gpa1 to endosomes.
Unique functions of myristate
Our findings suggest that Gpa1G2A/4K mimics the wild-type protein but is not
myristoylated and surprisingly, is also not mono-ubiquitinated. Potential explanations for this
finding are that the mono-ubiquitination machinery requires direct recognition of the
myristate moiety or recognition of a myristate-dependent conformational change in Gpa1.
Another possibility is that Gpa1G2A/4K somehow interferes with mono-ubiquitination.
Considering that this mutant can still be poly-ubiquitinated and is otherwise modified
correctly (i.e. palmitoylated) it seems unlikely that the lysine string itself is negatively
contributing to mono-ubiquitination.
In conclusion, we have exploited the unique advantages of our experimental system
to determine how the functional status of Gpa1 can influence the extent of ubiquitination.
Based on our data we can propose a model in which Gpa1 is degraded by two pathways. The
first pathway, used by the fully mature G protein, involves mono-ubiquitination, endocytosis,
and delivery to the vacuole. The second pathway, used by misfolded Gpa1, involves poly-
ubiquitination and delivery to the proteasome. This strong relationship between the activity,
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the extent of ubiquitination, and the trafficking of the G protein ? subunit to its site of
degradation establishes a new mechanism of G protein regulation.  Identifying proteins
involved in Gpa1 ubiquitination as well as determining how ubiquitination regulates Gpa1
signaling will be the focus of future studies.
EXPERIMENTAL PROCEDURES
Strains and plasmids - Standard methods for the growth, maintenance, and
transformation of yeast and bacteria, and for the manipulation of DNA, were used throughout
(9). Yeast Saccharomyces cerevisiae strains used in this study were BY4741 (MATa leu2?
met15? ura3?), BY4741-derived mutants lacking PEP4 or UBP12 (disrupted using the
KanMX G418-resistance marker, from Research Genetics, Huntsville, AL), BY4741-derived
mutant lacking both STE7 and GPA1 (GPA1 disrupted using gpa1::hisG and STE7 disrupted
using KanMX G418-resistance), MHY753 (MATa his3-?200 leu2?1 ura3-52 lys2-801
trp1?63 ade2-101), MHY754 (MHY753, cim3-1), CRY1 (MATa ura3-1 leu2,3-112 his3-11
trp1-1 ade2-1
oc can1-100), CB007-1D (CRY1, pep4-2::HIS3 prb1::LEU2), LHY488 (MATa
ura3-1 leu2,3-112 his3-11 trp1-1 ade2-1
oc
 can1-100), LHY489 (LHY488, pep4-2::HIS3
prb1::LEU2)  (provided by Linda Hicke, Northwestern University) (60), and YGS5 (MATa
ura3-52 lys2 ade2oc trp1 leu2-1 gpa1::hisG ste11ts) (139). STE2 was disrupted in BY4741
and BY4741-derived pep4? mutant strains by single-step gene replacement with ste2::HIS3
(this work).
Yeast shuttle plasmids used here were pRS316 (CEN, ampR, URA3), pRS406 (ampR,
URA3) (134), pRS316-GPA1 which contains GPA1 under the control of its native promoter
(139), pAD4M (2 µm, ampR, LEU2, ADH1 promoter/terminator, from Peter McCabe, Onyx
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Pharmaceutical), pAD4M-GPA1 (139), pND747 (2 µm, ampR, URA3, MYC-tagged ubiquitin
under the control of the CUP1 promoter, from Nicholas Davis, Wayne State University)
(124) and pRS425-FUS1-lacZ (74). pRS316-GPA1?128-236 was constructed by replacing the
1.5 kbp HindIII-HindIII fragment with an 1170 bp PCR product, generated using GPA1 as
template. The forward primer 5'-CCC AAG CTT TAA TTC ACG AAG ACA TTG CTA
AGG CAA TAA AGC AAC TTT GG- 3' disrupts and regenerates the GPA1 HindIII site; the
reverse primer 5'-AGG TCG ACG GTA TCG ATA AGC-3' flanks the multiple cloning site
HindIII upstream of the gene insert within pRS316. pAD4M-GPA1?128-236 was constructed
by PCR amplification of GPA1?128-236 using primers 5’-ACG CGT CGA CAT GGG GTG
TAC AGT GAG TAC GCA AAC AAT A-3’ and 5’-CGA GCT CTC ATA TAA TAC CAA
TTT TTT TAA GGT TTT GCT-3’, engineered with SalI and SacI sites, and subcloning into
the SalI/SacI sites within the multiple cloning site of the pAD4M vector. Note that positions
127 and 236 both encode Leu. A triple-Flag epitope tag was placed at the C-terminus of
Ubp12 (UBP12-Flag) by PCR amplification and subcloning into pYES2.1/V5-His-TOPO (2
?m, URA3, GAL1 promoter, CYC1 terminator) (Invitrogen, Carlsbad, CA), to yield plasmid
pYES-UBP12-Flag. PCR primers were 5'-CCC AAG CTT CCA GAA TGG GTT CTT CAG
ATG TTT CAA GTC-3' and 5'-G TTA CTT GTC ATC GTC ATC TTT ATA ATC CTT
GTC ATC GTC ATC TTT ATA ATC CTT GTC ATC GTC ATC TTT ATA ATC AAG
CTT TTC TGG CGA TTC TAG TGT CAC-3'.
The Gpa1-GFP (green fluorescent protein) fusion was constructed by PCR
amplification of the GPA1 gene, digestion with Xba1 and ClaI, and subcloning into the
corresponding sites of yeast-enhanced GFP-containing plasmid pUG35 (CEN, URA3, MET25
promoter, CYC1 terminator) (112). PCR primers used were 5’-CCT GCA GCC CGG GGG
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ATC CAC TAG TCT AGA-3’ (forward) and 5’-ACA TCG ATT ATA ATA CCA ATT TTT
TTA AGG TTT TGC TGG ATC-3’ (reverse), and include unique XbaI and ClaI restriction
sites. A cassette containing the promoter, GPA1-GFP, and terminator was digested with SacI
and KpnI and subcloned into the corresponding sites of integrating vector pRS406 to yield
pRS406-GPA1-GFP. The resulting plasmid was linearized with HindIII (a site unique to
GPA1) to direct gene integration. GPA1?128-236-GFP was constructed as described for GPA1-
GFP except for the use of a different forward primer (5’-GGT CTA GAC ATG GGG TGT
ACA GTG AGT ACG-3’) and GPA1?128-236 as the template.
The G2A, C3S, 4K, 1K, 2K, 5K, 6K, and 8K mutations were added to the various
constructs using site directed mutagenesis.  The templates used for G2A, C3S, 1K, and 2K
were wild-type Gpa1.  The poly-lysine mutants were created sequentially such that each
additional lysine was added using the previous lysine mutant as a template (4K uses 2K as a
template, 5K uses 4K as a template, etc.).
Growth, transcription, degradation and ubiquitination bioassays - The pheromone-
dependent growth inhibition (halo) and reporter-transcription assays were conducted as
described previously (74). Gpa1 expression and ubiquitination was monitored as described
previously (98). To monitor the loss of Gpa1, cultures were treated with cycloheximide (10
mg/ml in 0.1 % ethanol, final concentrations) for up to 120 min, as described previously (58).
Growth was stopped at mid-log phase (A600nm ~ 1) by the addition of 10 mM NaN3 and
transfer to an ice bath. Cells were centrifuged, washed with 10 mM NaN3, and the cell pellet
was resuspended directly in boiling SDS-PAGE sample buffer (62.5 mM Tris-HCl pH 6.8,
10% glycerol, 2% SDS, 1% 2-mercaptoethanol, 0.0005% bromphenol blue) for 10 min. The
samples were then subjected to glass bead homogenization, clarified by microcentrifugation,
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and resolved by SDS-polyacrylamide gel electrophoresis and transfer to nitrocellulose. The
membrane was probed with antibodies to Gpa1 at 1:1,000 (40), Ste4 at 1:2,000 (from Duane
Jenness, Univ. Massachusetts), or Pgk1 at 1:75,000 (from Jeremy Thorner, Univ. California
Berkeley). Immunoreactive species were visualized by enhanced chemiluminescence
detection (Pierce) of horse radish peroxidase-conjugated anti-rabbit IgG (BioRad).
Immunoprecipitation. The association of Gpa1 and Ubp12 was examined by
immunoprecipitation of Flag-tagged Ubp12 and immunoblotting with anti-Gpa1 antibodies.
Cells (50 ml) co-transformed with plasmids pAD4M-GPA1 and pYES-UBP12-Flag were
grown to A600nm ~ 1, harvested and resuspended in 550 ml of lysis buffer (50 mM NaPO4 pH
7.5, 400 mM NaCl, 0.1% Triton X-100, 10% glycerol, 0.5 mM dithiothreitol, 25 mM NaF,
25 mM glycerophosphate, 1 mM sodium orthovanadate, 10 mM N-ethylmaleimide, 5 mM
phenylmethylsulfonyl fluoride, and one pellet of complete EDTA-free protease inhibitor
cocktail (Roche)). This and all subsequent manipulations were carried out at 4 °C. Cells were
subjected to glass bead vortex homogenization for 30 s, repeated eight times, and centrifuged
twice at 6,000 x g for 5 min and 25 min. Lysates were incubated for 2 h with a bead volume
of 10 ml of anti-Flag M2 affinity resin (Sigma) equilibrated in lysis buffer.
Immunoprecipitates were collected by centrifugation at 1,000 x g for 30 s, and pellets were
washed with 1 ml of lysis buffer for 3 min, repeated four times before final resuspension in
30 ml of 2x SDS-PAGE sample buffer. Each sample was resolved by 7.5% polyacrylamide
gel electrophoresis and immunoblotting with anti-Gpa1 polyclonal antibodies at 1:1,000 or
anti-Flag monoclonal antibodies at 1:2,000.
Microscopy analysis. Cells expressing single-copy, integrated GFP-tagged gene
fusions were visualized by differential interference contrast (DIC) and fluorescence
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microscopy using a Nikon eclipse E600EN, photographed with a Hamamatsu digital camera,
and analyzed with MetaMorph Version 5.0 software.
MAPK phosphorylation assays—Yeast strains were grown with shaking at 30°C in
selective media to A600 nm ~0.8 and treated with 3 µM ?-factor pheromone. Samples were
removed at timed intervals, collected by centrifugation, and stored at -70° C. To prepare
extracts, cell pellets were thawed on ice and resuspended in 250 µl of ice cold TCA buffer
(10 mM Tris pH 8.0, 10% trichloroacetic acid, 25 mM NH4OAc, 1 mM EDTA). Cells were
disrupted by vortexing with 100 µl of glass beads in 5 x 1 min bursts with chilling on ice in
between. Lysates were transferred to new tubes and centrifuged for 10 min at 16,000 x g at
4°C. Pellets were resuspended in 0.1 M Tris pH 11.0, 3% SDS, and boiled for 5 min, then
centrifuged at 16,000 x g. The resulting supernatant was separated and protein concentration
was determined using the DC protein assay (Bio-Rad Laboratories). 20 µg of protein in 2x
SDS-PAGE sample buffer was used per time point. MAPK phosphorylation was determined
by 12% SDS-PAGE and immunoblotting with p44/42 MAPK antibody at 1:500 (Cell
Signaling Technology). Densitometry of developed blots was determined using ImageJ.
Protein Folding Simulation Algorithms – Identification of destabilizing mutations in
yeast Gpa1 was accomplished using Medusa protein modeling software (PMID 16839198).
Briefly, Medusa models a protein in atomic resolution and features a physical force field as
well as a rapid amino acid sidechain packing algorithm to recapitulate changes in protein fold
stability upon amino acid substitution with high accuracy (PMID 18073107; 17538626).
Since the structure of yeast Gpa1 is unknown, we used its mammalian homolog, G?i, as the
modeling system.  G?i exhibits 67% sequence similarity with Gpa1, and its structure has
been solved by high resolution x-ray crystallography (PDB code:  1agr).  Using the Medusa
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software, we conducted an alanine scan to systematically evaluate the stability change due to
structural perturbation upon substituting the native amino acid with alanine along the entire
G?i sequence.  The stability of the mutant is computed with the relaxed structure and
mutation-induced stability change (??G) is obtained by subtracting the wild type stability.
Finally, the destabilizing mutations are mapped onto the yeast Gpa1 sequence and only
evolutionarily-conserved residues are selected as the putative destabilizing mutant.  To
minimize disruption of the G protein function, we avoided mutating residues associated with
nucleotide catalysis, switch regions, or other protein binding regions.
CHAPTER III
Development of a Cell Viability Assay to Monitor for Palmitoylation of Gpa1
All Figures contributed by Michael J. Lee
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Summary
Protein palmitoylation is the post-translational addition of a 16-carbon lipid to a
substrate protein, via a thioester linkage.  Modifications of this type are known to be critical
factors in anchoring peripheral membrane proteins to lipid bilayers, and recent evidence
suggests that reversible palmitoylation may play a role in signal regulation. However, our
understanding of how proteins are palmitoylated is underdeveloped. Progress has been
hampered by the lack of sensitive assays for monitoring protein palmitoylation in vivo.   
Gpa1, the G? subunit in the yeast mating response pathway, is palmitoylated.  Blocking
palmitoylation—which can be achieved by mutating the palmitate-acceptor cysteine
residue—results in only minor signaling defects.  Here we describe a variant of Gpa1 that is
functional only if palmitoylated.  By replacing the myristoylated glycine-2 with a short
stretch of basic amino acids, palmitoylation becomes absolutely required for Gpa1 targeting
to the plasma membrane, and sequestration of G?? subunits.  The availability of this mutant
makes it possible to screen for Gpa1 palmitoylation in vivo, using cell viability as a reporter.
Furthermore, we provide proof of the screening principle, and preliminary data suggesting
redundancy among a subset of known protein acyl-transferases (PATs).
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INTRODUCTION
Heterotrimeric guanine nucleotide-binding proteins (G proteins) are a large and
diverse family of signal regulators (61).  These G protein signaling systems regulate
responses to a wide variety of chemical and environmental signals, including hormones,
neurotransmitters, odors and light. The signaling complex is comprised of three subunits,
which signal as two entities: G?  and G??.  These subunits, through their coupling to
transmembrane receptors, function as signal mediators, connecting signals from outside the
cell with effectors inside the cell.  G? functions as a signaling switch; it binds to either GDP
or GTP, and differentially to effector proteins depending on its nucleotide bound state.
G proteins exist in essentially all eukaryotic organisms, including the yeast
Saccharomyces cerevisiae.  In yeast, G proteins mediate mating, the process by which two
haploid cells fuse to create a single diploid cell.  The mating response is characterized by
growth arrest, polarized cell morphology and the transcription of a new subset of genes
required for the cell fusion process.  All of these responses are regulated by G protein
activation (41).
In recent years, it has become increasingly clear that G proteins exist at multiple
locations inside the cell, in addition to their well-established location at the plasma
membrane (35). Furthermore, it has become evident that some G proteins re-localize in
response to activation, opening up the possibility that signaling is occurring from multiple
cellular compartments (118).  Thus, understanding the mechanisms by which G proteins
localize to various cellular locations is vital to understanding how G protein function is
regulated.  One such example comes from yeast, where the G? subunit Gpa1 is known to
exist at the cell periphery and at endosomes (135).  At the plasma membrane, Gpa1 regulates
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the function of the G?? subunit Ste4/Ste18, and at the endosome, Gpa1 regulates the function
of the phosphatidyl inositol 3-kinase (PI3K) Vps34 (136).  As with other G? subunits, it is
not fully understood what signals regulate Gpa1 localization to the plasma membrane or to
the endosome.
G proteins are anchored to the inner leaflet of lipid bilayers through the post-
translational addition of a variety of lipid modifications.  For G? subunits, principle among
these modifications are myristoylation and palmitoylation (24).  All G? subunits are either
myristoylated, palmitoylated, or modified by both lipids.  Myristoylation of G? subunits is
well understood at the biochemical level; the consensus sequences have been identified, and
the enzymes responsible for N-terminal myristoylation are known (17). G?  subunit
palmitoylation is less well understood.  It is not clear what constitutes a “palmitoylation site,”
although it is known that the lipid is attached to cysteine residues, and the enzymes
responsible for palmitoylation of most proteins have not been identified.
The identification of enzymes involved in palmitoylation is in its infancy.  Recently,
the DHHC motif was identified because of its presence in both Erf2 and Akr1—the first two
proteins shown to function as protein acyl-transferases (PATs).  Erf2 regulates the
palmitoylation of Ras2, whereas Akr1 palmitoylates type I casein kinases (11, 52).  To date,
7 DHHC proteins have been identified, all in yeast, and all are now known to function as
PATs (104).  Even so, it is unlikely that these seven DHHC proteins truly represent all PATs
in existence, but rather those of a single PAT sub-family.  A comprehensive genome-level
screen was recently performed to identify palmitoylated proteins in yeast, as well as to
determine PAT-substrate pairs (125).  After these efforts, 35 new palmitoylated proteins were
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identified, but PATs have still not been identified for the vast majority of palmitoylated
proteins.
The yeast G?  subunit Gpa1, and many other G?  subunits, is known to be
palmitoylated (92), however, it is still not clear what proteins are involved in the addition of
palmitate to Gpa1 or to any other G?.  One difficulty in identifying a PAT for Gpa1 is that
palmitoylation in this case has only very mild effects on activity (96, 138).  In yeast—an
organism whose value often rests in its utility for genetic screens—the lack of a strong
palmitoylation phenotype complicates the ability to perform high throughput genetic
screening for palmitoylation-defective mutants.  Here, we characterize Gpa1G2A/2K, a novel
mutant form of Gpa1 that can be used to screen for defects in palmitoylation.  Unlike the
wild-type form of Gpa1, cells that express Gpa1G2A/2K are only viable if properly
palmitoylated.  Furthermore, using this mutant, we provide data suggesting that no currently
known PAT is necessary for Gpa1 palmitoylation.  These findings suggest either redundancy
or another as yet unidentified PAT for Gpa1.
RESULTS
Mis-palmitoylated Gpa1 displays only minor defects in signaling and localization
Gpa1 is palmitoylated on cysteine-3, however, it is not clear how this modification is
regulated.  Understanding this process is particularly relevant because Gpa1 is known to
localize to multiple intracellular membranes, and palmitoylation is one of the few membrane
anchors known to be reversible (45).  In order to identify proteins involved in palmitoylating
Gpa1, we first needed to identify a robust phenotype that could be used for high-throughput
genetic screening.  Because palmitoylation is known to regulate Gpa1 localization to the
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plasma membrane, we began by monitoring protein localization in cells expressing Gpa1-
GFP or Gpa1C3S-GFP.  We found that introducing the C3S substitution did not significantly
alter the localization of Gpa1 (Figure 3.1 B).  Likewise, adding C3S did not alter the
localization of Gpa1 harboring the G2A/4K substitution, which replaces myristoylation with
a poly-basic stretch (Figure 3.1 C, see Chapter II for validation of mutant). As another
measure, we monitored pheromone sensitivity in wild-type cells and in cells that express a
palmitoylation-deficient Gpa1, Gpa1C3S.  The addition of mating pheromone to a nascent
lawn of cells is known to cause a zone of growth inhibition due to G?? signaling; the size of
the restricted growth zone is proportional to the cell’s sensitivity to pheromone.  When
compared to wild-type yeast, cells expressing Gpa1C3S were more sensitive to pheromone
(Figure 3.2 A) (96, 138), presumably because the lack of palmitoylation resulted in less Gpa1
at the plasma membrane to sequester G??.  Although the Gpa1C3S cells were more sensitive
to pheromone, the difference in sensitivity (halo size) was only 15%, a phenotype that is
likely too subtle to be useful in high throughput genetic screening.  Monitoring the pathway
at the level of mating gene transcription showed a similarly subtle defect in Gpa1C3S
expressing cells (138).
The lack of difference between wild-type and Gpa1C3S cells was surprising.  Other
G? subunits show severe localization and signaling defects when not palmitoylated (116).
We noticed, however, that as opposed to some other G? subunits, Gpa1 has two N-terminal
lipid modifications: myristoylation and palmitoylation.  When G?? is considered as one of
the membrane anchors, wild-type Gpa1 actually has three membrane-localization signals,
leaving the Gpa1C3S mutant with two intact membrane anchors.  Thus, we next wanted to test
the hypothesis that Gpa1 is resistant to defects when not palmitoylated because of the
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presence of two other membrane-localization signals.  To do so, we needed a form of Gpa1
that is absolutely dependent on being palmitoylated.
Blocking Gpa1 myristoylation (using the G2A substitution), results in protein that is
also not palmitoylated, not membrane bound, and not functional.  We have previously
determined that Gpa1G2A/4K—a mutant form that cannot be myristoylated but has a poly-
lysine stretch in its place—is membrane bound and functional (see Chapter II) (156).  Poly-
basic stretches have been used to rescue membrane localization of Ras and even G?s in the
absence of lipid modification (103, 154).  Also, it is believed that naturally occurring poly-
basic stretches are utilized by some G? subunits to aid in membrane attachment (116).  We
reasoned that the Gpa1G2A/4K mutant, or some variant of this mutant, could be used to confer
an absolute dependence on palmitoylation for Gpa1 activity.  Palmitoylation is known to
occur in a myristoylation-dependent manner, but it is believed that myristate only serves to
localize the protein to the plasma membrane, where palmitoylation can occur (46, 96).  If this
is the case, Gpa1G2A/4K should also be palmitoylated, despite the lack of myristoylation.  To
test if this is true, we again compared pheromone sensitivity in cells expressing Gpa1G2A/4K to
cells expressing Gpa1G2A/C3S/4K.  The “C3S” mutation should block palmitoylation (138).  We
found that Gpa1G2A/C3S/4K cells were approximately 15% more sensitive to mating pheromone
as compared with cells expressing Gpa1G2A/4K (Figure 3.2).  A similar difference was
observed when comparing Gpa1 and Gpa1C3S, suggesting that Gpa1G2A/4K is indeed
palmitoylated.
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Figure 3.1
A
B
WT                               C3S
C
G2A/4K G2A/C3S/4K
Gpa1   M G C T V S T Q T  I  G D E S
Gpa1C3S   M G S T V S T Q T  I  G D E S 
Gpa1G2A/1K  M A C T V S T Q K  I  G D E S
Gpa1G2A/2K  M A C T V S T K K  I  G D E S
Gpa1G2A/4K  M A C T V S K K K K G D E S
Gpa1G2A/C3S/4K M A S T V S K K K K G D E S
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Figure 3.1  Gpa1 lacking the palmitoylated Cys residue remains membrane bound.  (A)
Alignment of N-terminal amino-acids of various palmitoylation mutants used in this study.
(B) ste7? gpa1? cells were transformed with an integrating plasmid (pRS406-GPA1-GFP, or
indicated mutant in pRS406-GPA1-GFP plasmid) containing the native GPA1 promoter and
gene fused to the gene encoding yeast-enhanced green fluorescent protein. Cells were grown
to mid-log phase at 30 oC and visualized by DIC and fluorescence microscopy. Cells
expressing Gpa1 alone exhibited negligible background autofluorescence (data not shown).
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Figure 3.2  Gpa1
G2A/4K
 requires the palmitoylated Cys residue to retain full pheromone-
sensitivity. ste7? gpa1? was transformed with single copy plasmids pRS315-STE7 and
either pRS316-GPA1 (WT), pRS316-GPA1G2A/4K (G2A/4K), pRS316-GPA1C3S (WT+C3S),
or pRS316-GPA1G2A/C3S/4K (G2A/4K+C3S), with each gene under the control of its native
promoter.  Transformed cells were plated onto solid medium and exposed to paper discs
containing ?-factor pheromone (clockwise from bottom right:  1.5, 4.5, 15, and 45 µg)
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Gpa1
G2A/1K 
and Gpa1
G2A/2K
, but not Gpa1
G2A/4K
 or wild-type Gpa1, must be
palmitoylated to maintain viability
Having found evidence that the unmyristoylated Gpa1G2A/4K also requires the
palmitoylated Cys for full function, we next determined if a shorter lysine stretch could
confer a dependence on palmitoylation.  Our rationale was that a short poly-lysine stretch
represented a “weaker” membrane localization signal than myristate or palmitate, and might
not support membrane localization alone.  In order to test this hypothesis, we altered the
length of the lysine stretch from 4 residues to 1 residue (4K to 1K), and monitored both
viability and pheromone sensitivity (Figure 3.1).  We found that all lysine mutants were
viable (Figure 3.3 A), suggesting that even a single lysine placed near the N-terminus of
Gpa1 was sufficient to rescue the inviability associated with the Gpa1G2A (unmyristoylated)
mutant.  Furthermore, we found that pheromone sensitivity was inversely proportional to the
length of the lysine stretch (Figure 3.3 B).  G ? ? is known to facilitate the membrane
localization of G? (50); the addition of mating pheromone should decrease interaction
between G? and G??, placing a greater burden on G? to sustain its own membrane binding.
In this way, the increased pheromone sensitivity supports our hypothesis that Gpa1 mutants
with a shorter lysine-stretch will depend more greatly on palmitoylation.
To determine if Gpa1 mutants with short lysine-stretches require the palmitoylation
site Cys for viability, we introduced the C3S substitution into each of our lysine mutants.
Each mutant was expressed behind the endogenous GPA1 promoter in the YGS5 strain
(ste11ts gpa1?).  As shown above, we found that all lysine mutants were viable if the
palmitoylation site was left intact (Figure 3.4 A). However, we also found that mutants of
Gpa1 with one lysine or two lysines were not viable if palmitoylation was blocked (Figure
89
3.4 A).  Mutants with 4 or more lysines were viable with or without the palmitoylated Cys, as
was wild-type Gpa1 (Figure 3.4 A and data not shown).  At 34° C, where the ste11
MAPKKK is not functional and signaling does not occur, all cells were equally viable
showing that the defects were limited to membrane binding/G?? sequestering capability of
the Gpa1 mutants (Figure 3.4 B).  These data suggest that Gpa1G2A/1K and Gpa1G2A/2K could
be used in a screen for proteins involved in Gpa1 palmitoylation.
None of the known PATs are alone necessary for palmitoylation of Gpa1
We have developed the first cell viability screen for Gpa1 palmitoylation.  Given the
genomic tools available in yeast, it now should be feasible to identify proteins involved in
this process.  We began by asking whether any of the known PATs was alone necessary for
the palmitoylation of Gpa1.  We would expect that the deletion of a critical PAT would result
in inviability of the cells expressing Gpa1G2A/2K. Using the YGS5 strain as above, we found
that Gpa1G2A/2K conferred viability in each of the known PAT deletions (Figure 3.5).
Although it is difficult to make any broad conclusions from these data, our findings suggest
that none of the known PATs are alone necessary for palmitoylation of Gpa1.
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Figure 3.3
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Figure 3.3  The palmitoylated Cys residue is necessary for viability of cells
expressing Gpa1G2A/1K or Gpa1G2A/2K, but not Gpa1G2A/4K or wild-type Gpa1.
YGS5 strain cells were transformed with single copy plasmids pRS316-GPA1 or the
indicated mutant in the pRS316-GPA1 plasmid, each containing the native GPA1
promoter region.  Cells were grown at 34° overnight to saturation.  3µl of each
saturated culture was spotted in serial 2-fold dilutions on selective media agar plates,
and incubated either at 34° or room-temperature until colonies began to form (3-5
days).
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Figure 3.4
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Figure 3.4  No known PAT is necessary for Gpa1  palmitoylation.  PAT genes
disrupted with the KanMX resistance marker were amplified from BY4741-derived
strains harboring the gene deletions and transformed into the YGS5 strain.  The
resulting strains were then transformed with single copy GPA1 plasmids and spotted
as in Figure 3.3.
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DISCUSSION
Screening for palmitoylation using poly-lysine mutants of Gpa1
The principle finding of this study is that mutants of Gpa1 that are not myristoylated
but have a short poly-lysine stretch near the N-terminus can be used to screen for proper
palmitoylation.  The value of this new screening approach is that strains can be screened for
viability rather than for subtle differences in the mating response. Using this new tool, we
tested whether deletion of any of the known DHHC family PATs affected the palmitoylation
status of Gpa1.  We were unable to identify any single gene deletion that results in mis-
palmitoylation of Gpa1.  These findings represent only a preliminary investigation of Gpa1
palmitoylation, and are presented mainly to show the feasibility of this new screening
method.  In order to more fully understand the role played by the known DHHC family
members in Gpa1 palmitoylation, we will need to repeat these experiments in cells in which
various PATs are deleted in combination.
One of the interesting findings from this study is that a single lysine near the N-
terminus of Gpa1 was sufficient to rescue the inviability associated with the lack of Gpa1
myristoylation.  Addition of this single lysine (at amino acid position 9) was not sufficient,
however, to fully rescue membrane localization, as monitored using a GFP-tagged version of
the protein (data not shown).  Our presumption is that the membrane-cytoplasm equilibrium
of the Gpa1G2A/1K mutant is heavily in favor of cytoplasmic localization, however, the small
amount of protein at the plasma membrane is sufficient to decrease G?? signaling to below
the threshold required for growth arrest. Poly-basic stretches have been used previously to
rescue the membrane localization of signaling proteins, such as Ras (103).  The fact,
however, that Gpa1G2A/1K was at all viable did come as a surprise, as there are no reports of a
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single basic charge being sufficient for membrane attachment. In the N-terminal region, two
separate small basic patches do exist (K21, R22 and K35, R37).  It is likely that the single
basic charge adds to a general basic nature already in existence in that area of the G protein,
raising the charge above the threshold required to function as a membrane anchor.
Redundancy among the PATs for Gpa1
One potential explanation for the lack of phenotype in the PAT deletion strains is that
redundancy exists among these proteins in their ability to palmitoylate Gpa1.  This question
was recently addressed in a genomic effort to identify all palmitoylated proteins in yeast
(125).  The authors used a three-step extraction protocol called acyl-biotinyl exchange
(ABE), which allows for specific biotinylation of palmitoylated proteins.  Using this
procedure, Roth et al found that six of the seven known PATs must be deleted before Gpa1 is
no longer palmitoylated.  
Another possibility is that other, as yet unidentified, proteins have palmitoyl-
transferase activity. Seven DHHC family members exist in yeast, however, it is possible that
other non-DHHC proteins also have PAT function.  Using Gpa1G2A/2K in a genome-wide
screen would identify other PATs, and could potentially identify additional proteins required
for G protein palmitoylation.  Furthermore, the idea of using a short lysine stretch to replace
a lipid modification could be used on any protein that contains multiple lipid modifications.
Using our findings as a model, proteins other than G? subunits could feasibly be made
amenable for similar screens.
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EXPERIMENTAL PROCEDURES
  Strains and Plasmids—standard methods for growth, maintenance, and
transformation were used throughout (9).  Yeast strains used in this study were BY4741
(MATa leu2? met15? his3? ura3?), BY4741-derived mutants lacking GPA1 and STE7
(GPA1 was disrupted using a gpa1::hisG deletion plasmid that allows for deletion of Gpa1
and recovery of the URA3 marker; STE7 was disrupted using the KanMX G418-resistence
marker; Yeast Deletion Clones, Invitrogen, Carlsbad, CA), YGS5 (MATa ura3-52 lys2
ade2
oc
 trp1 leu2-1 gpa1::hisG ste11
ts), and YGS5-derived strains lacking either APT1,
AKR1, AKR2, SWF1, ERF2, PFA3, PFA4, or PFA5.  Each gene was deleted using the
KanMX G418-resistence marker.
Yeast shuttle plasmids used here were pRS316 (CEN, ampR, URA3), pRS315 (CEN,
ampR, LEU2), pRS316-GPA1 which contains GPA1 under the control of its native promoter
(139), pRS315-STE7 which contains STE7 under the control of its native promoter (161),
and pRS316-GPA1C3S (138).  pRS316-GPA1G2A/1K was created by site directed mutagenesis
using pRS316-GPA1G2A (139) as a template and mutagenic primer 5’- CA GTG AGT ACG
CAA AAA ATA GGA GAC GAA AGT GAT CC – 3’ and its complement.  pRS-
GPA1G2A/2K and pRS-GPA1G2A/4K were created using pRS316-GPA1G2A/1K as a template and
the mutagenic primers 5’- GCG TGT ACA GTG AGT ACG AAA AAA ATA GGA GAC
GAA AGT GAT CC – 3’ (for 2K) and 5’- GCA TGT ACA GTG AGT AAG AAA AAA
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AAA GGA GAC GAA AGT GAT CC – 3’ (for 4K), and their complements, respectively.
The “C3S” mutation was added to each of the pRS316-GPA1 contructs described above
using site directed mutagenesis and the various plasmids described above as templates.
Mutagenic primers were 5’- AGG TAG GAA ATA ATG GGG TCT ACA GTG AGT ACG
CAA – 3’ and its complement.
Pheromone sensitivity/growth arrest assay (Halo Assay)—halo assays were
performed as described previously (74).  Briefly, cells were grown to saturation in selective
media and 100 µl of the culture was added to a 4 ml of liquid 0.5% agar solution (melted and
cooled to 55°C).  Agar-cell solution was spread onto selective plates and allowed to solidify.
Various concentrations of ? mating factor (pheromone) were added to paper discs, which
were then applied to the solidified agar.  Cells were allowed to grow for 48 hours, and zones
of growth inhibition measured.
Viability Screen (serial dilutions)—viability of cells was determined by growing cells
to saturation at the permissive temperature (34°C).  Saturated cells were diluted in sterile
water in 1:2 serial dilutions; and 3µl of each dilution was spotted onto a selective media-agar
plate and allowed to dry.  Plates were spotted in duplicate, and one plate was incubated at
34°C while the other was incubated at room temperature.  After 4 days, cells plates were
scored for viability (+/- growth and # of colony forming units).
CHAPTER IV
Identification and Characterization of a Non-Receptor Exchange Factor for the Yeast
G? Subunit Gpa1
Elements of the work referenced in this chapter has been accepted for publication:
Lee, M.J, and H.D. Dohlman.  (2008) Co-activation of G protein signaling by cell-
surface receptors and an intracellular exchange factor.  Curr Biol 18:211-5.
All figures contributed by Michael J. Lee
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SUMMARY
G protein-coupled receptors (GPCRs) mediate responses to a broad range of chemical
and environmental signals. In yeast a pheromone-binding GPCR triggers events leading to
the fusion of haploid cells. In general, GPCRs function as guanine nucleotide exchange
factors (GEFs); upon agonist binding the receptor induces a conformational change in the G
protein ? subunit, resulting in exchange of GDP for GTP and in signal initiation. Signaling is
terminated when GTP is hydrolyzed to GDP (141). This well-established paradigm has in
recent years been revised to include new components that alter the rates of GDP release, GTP
binding (1, 15, 27, 43, 69, 151, 168), and GTP hydrolysis (41, 111). Here we report the
discovery of a non-receptor GEF, Arr4. Like receptors, Arr4 binds directly to the G protein,
accelerates guanine nucleotide exchange, and stabilizes the nucleotide-free state of the ?
subunit. Moreover, Arr4 promotes G protein-dependent cellular responses including
mitogen-activated protein kinase (MAPK) phosphorylation, new gene transcription and
mating. In contrast to known GPCRs, however, Arr4 is not a transmembrane receptor, but
rather a soluble intracellular protein. Our data suggest that intracellular proteins function in
cooperation with mating pheromones to amplify G protein signaling, thereby leading to full
pathway activation.
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INTRODUCTION
Heterotrimeric G proteins respond to a wide variety of chemical and sensory signals
and are highly conserved in eukaryotic organisms, including yeast and humans.  In the well-
established paradigm of G protein signaling (61) inactive G?-GDP associates with both a
seven-transmembrane spanning G protein coupled receptor (GPCR) and the G?? dimer.
Upon ligand binding, GPCRs act as guanine nucleotide exchange factors (GEFs), inducing
conformational changes in the three flexible “switch” regions in G?, resulting in GDP
release, and subsequent GTP binding.  GTP-bound G? no longer interacts with G??, and
both entities are free to activate downstream effectors.  The signal is terminated when G?
hydrolyzes GTP to GDP, and the inactive heterotrimer is reformed.
 This paradigm, although still largely true, has been expanded to account for the
discovery of additional proteins involved in the G protein signaling cycle.  Proteins in the
Regulator of G protein Signaling (RGS) family were discovered 10 years ago to function as
GTPase Accelerating Proteins, or GAPs, for G? subunits (110). More recently, proteins in
the GoLoco family were discovered to function as Guanine-nucleotide Dissociation
Inhibitors, or GDIs, for G? subunits (168).  Both RGS and GoLoco proteins have since
proven to be critical components of G protein signaling.
In the yeast Saccharomyces cerevisiae, a single heterotrimeric G protein regulates a
cell fusion event called mating.  Yeast can exist as haploid cells of either the a- or ?- mating
type and secrete mating pheromones, a-factor and ?-factor, respectively.  Binding of
pheromone to receptors on adjacent cells induces growth arrest in G1, polarized growth
towards the mating partner, and new gene transcription in preparation for cell fusion.  Most
of the components of this signaling cascade were identified genetically as deletions that
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resulted in a mating-deficient (sterile) phenotype. Included are genes that encode a GPCR
(STE2), G? and G? subunit (STE4 and STE18), but not a G?.  Deletion of Gpa1, the G? of
the mating pathway, does not result in a sterile phenotype, but rather a constitutively active
signal, due to the uncontrolled activation of G??.  Subsequent data showing that G?? was
both necessary and sufficient to activate the mating signal left the conclusion that G? played
no active role in this process (as reviewed in (42).
We recently reported, however, that a constitutively active (GTPase-deficient) mutant
Gpa1 alone activates some components of the mating response (136).  We were surprised to
find that this required both the regulatory and catalytic components of the sole yeast
phosphatidyl inositol-3 kinase (PI3K), Vps15 and Vps34.  This was particularly interesting
because Vps15/Vps34 are known to exist primarily at the late endosome in yeast.
Subsequently, we determined that activated Gpa1 also exists at late endosomes, binds to
Vps34, and activates Vps34 kinase activity.  Thus, our conclusion was that Gpa1 at late
endosomes activates a unique signal through the PI3K Vps34.  Although G proteins have
long been known to exist at intracellular sites, this was the first evidence in any system of an
active signaling function of a G protein away from the cell periphery.
Further investigation also revealed that Vps15 is structurally similar to known G?
subunits.  In fact, Vps15 is also functionally similar to known G? subunits, in that it: 1)
interacts directly with Gpa1 in a GDP dependent manner, and 2) is required for the proper
localization of Gpa1.  Thus our findings suggest that Vps15 is an atypical G? subunit for
Gpa1 at the late endosome.  Having established the existence of atypical effectors
(endosomal Vps34) and atypical G?s (Vps15), we next chose to determine whether atypical
activators also exist in yeast.  Activation of G? subunits by non-receptor proteins has been
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shown recently for Ric-8a and some of the AGS proteins (15, 151).  Using a candidate gene
approach, we screened for genes that activate Gpa1.  Here, we report the identification of a
novel GEF for Gpa1, a protein called Arr4.   Arr4 was previously identified in a yeast-2-
hybrid screen as a Gpa1 interacting protein (75). Using biochemical, genetic, and cellular
analyses, we determine that Arr4 acts as a GEF for Gpa1 in vitro and is an activator of Gpa1
signaling in vivo.   Furthermore, we find that activation of Gpa1 by Arr4 is necessary for
normal pheromone-induced signaling.  Cells that lack Arr4 show lower levels of pheromone-
induced transcription, and lower levels of mating.  Our findings contribute to the growing
understanding that non-receptor GEFs contribute to signaling through heterotrimeric G
proteins.
RESULTS
Screen for a novel GEF in yeast
Heterotrimeric G proteins are well known to function as signal transducers, coupling
receptors at the cell surface to specific enzymes inside the cell. Recent research has
uncovered the existence of non-receptor activators of G protein signaling, including a non-
receptor GEF Ric-8a (1, 15, 27, 43, 69, 151). It is not known however whether such factors
contribute to GPCR signaling. A number of screens have been performed in yeast,
specifically to identify non-receptor activators, but none have attempted to identify
endogenous yeast proteins.
To address this question, we investigated if the yeast mating-response pathway makes
use of a non-receptor GEF.  When designing our screen, we first considered that there is no
common domain, or signature sequence, or predictive fold that is indicative of GEF activity.
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Figure 4.1  Screen for a novel GEF in yeast.  The screen for unidentified GEFs focused on
two G? binding characteristics:  nucleotide-dependent interaction, and selective binding to
the dominant negative mutant Gpa1N388D.  Our screen covered 27 proteins, all previously
shown to interact with Gpa1.  All experiments were performed using TAP-tagged versions of
candidate GEFs.  TAP purified cell extracts were probed with anti-Gpa1 antibodies to
monitor Gpa1 binding.
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In the absence of these physical features, we chose nucleotide-dependent binding for our
screening criteria.  Accordingly, we considered 27 proteins reported to bind to the yeast G?
subunit Gpa1 (Table 4.1). Of the proteins we tested, seven exhibited preferential interaction
with GDP-bound Gpa1 compared to the constitutively-active GTP-bound Gpa1Q323L (Figure
4.1). GDP-dependent binding is a common characteristic of GEFs for small GTPases (122),
as well as for Ric-8a (151). Since G? subunits and other GDIs also bind preferentially to G?
in the GDP-bound state, we next determined which of the candidate proteins preferentially
interact with the G? mutant Gpa1N388D, previously determined to form a stable but non-
productive complex with a known GPCR and GEF Ste2 (binding was observed even in the
absence of pheromone) (171). Our rationale was that the known GEF bound preferentially to
this mutant, so we anticipated that the mutant G protein might bind preferentially to other
proteins having exchange factor activity as well. Of the seven candidates tested, only Arr4
and Reg1 bound preferentially to Gpa1N388D. Notably, Arr4 is expressed as a dimer, as are
many GPCRs including Ste2 (101, 115). Relative to total expression Arr4 co-purified 8-fold
more Gpa1N388D than Gpa1, and 3-fold more Gpa1 than Gpa1Q323L (Figure 4.2 A and B). A
similar preference was shown previously for binding to Ste2 (171).
Direct, nucleotide-dependent, subtype-selective interaction between Arr4 and Gpa1
We next investigated whether Arr4 over-expression activates G protein signaling in
vivo. Over-expression of a GEF, even in the absence of any stimulus, often increases basal
activation of the G protein. For example, over-expression of Ric-8a leads to increased basal
phospho-ERK production in CHO cells (95). Similarly, we found that over-expression of
ARR4 induced a 3.5-fold increase in the basal transcription of Gpa1-dependent mating genes
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Figure 4.2
A B
C D
Figure 4.2  Arr4 as a GEF candidate.  (A) Cells expressing Arr4-TAP were
transformed with vector (pAD4M) containing either no insert, GPA1, GPA1Q323L or
GPA1N388D. TAP fusion protein was purified (IP) using Calmodulin-Sepharose resin,
eluted in SDS-PAGE sample buffer, and resolved by immunoblotting (IB) with Gpa1
antibody. Gpa1 typically migrates as a doublet of 52 and 54 kDa, representing the
myristoylated and unmyristoylated forms of the protein, respectively . (B)
Densitometry of data in panel A expressed as Gpa1 bound relative to total Gpa1
expressed. Data are mean ± SD of 3 separate experiments. (C) BY4741 wild-type cells
co-expressing FUS1-lacZ and vector (pAD4M) containing either no insert, ARR4, or
dimerization-deficient mutant arr4CCTT were monitored for β-galactosidase activity.
(D) Effect of known mating components on Arr4 activity. Experiment performed as in
(C), except that receptor (ste2) or MAPK kinase (ste7) deletion strains were used
when noted. Results for (C) and (D) are the mean ± SEM for 3 individual experiments
each performed in triplicate.
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(FUS1-lacZ, see below) (Figure 4.2 C). Over-expression of the receptor Ste2 yields a
comparable (~ 3-fold) increase in basal FUS1-lacZ expression (data not shown), while
pheromone binding produces an even larger (~50-fold) increase in activity. This phenotype
was dependent on the function of Arr4, as over-expression of a dimerization-deficient mutant
Arr4CCTT had no effect (101). Furthermore, Arr4-stimulated transcription required mating
pathway effectors, such as Ste7, but not the pheromone receptor Ste2 (Figure 4.2 D). Basal
activation by Arr4 was equivalent in the presence and absence of receptor; however the
baseline activation was higher in the absence of receptor, as noted previously (67).  The
mechanism by which Ste2 dampens basal activity is unknown, but may result from
sequestration of the G protein heterotrimer and dampening of spontaneous activation in the
absence of a pheromone signal. These data suggest that Arr4 functions as a GEF for Gpa1 in
vivo.
To determine whether the interaction between Arr4 and Gpa1 is direct or facilitated
by another protein, we purified 6xHIS-Gpa1 and GST-Arr4 from E. coli and reconstituted
these proteins in the presence of GDP or GDP plus AlF4
- (a transition state mimic that
induces the activated conformation of G?). Consistent with our in vivo observations, purified
Arr4 co-precipitated more efficiently with the GDP-bound form of Gpa1 than with GDP-
AlF4
--bound Gpa1 (Figure 4.3 B, lanes 1-6). Arr4 did not interact with Gpa2, the only other
G? subunit in yeast (Figure 4.3 B, lanes 7-12).
Arr4 was shown to be a copper-binding protein, and copper induces Arr4 dimer
formation (101). As noted above Arr4 dimerization is required for Gpa1-mediated signaling
in vivo (Figure 4.2 C). Dimerization is likewise required for strong binding to G?, since Arr4
in the absence of copper bound poorly to Gpa1 in vitro (Figure 4.3 A). Copper did not
107
Figure 4.3
A
B
Figure 4.3  Arr4 binds directly to Gpa1.  (A) and (B) Experiments performed using
recombinant purified components (E. coli). 100 nM of each protein was combined,
purified with GST-Sepharose resin (IP), resolved by SDS-PAGE and probed with
penta-HIS, Gpa1, or GST antibodies (IB). Note that the same protein preparations
were used in the functional assays presented in Fig. 3. (A) Binding with or without
150 nM CuSO4 (Cu) when noted. (B) Arr4 binding to Gpa1 versus Gpa2 was
performed as in panel A except that CuSO4 was present in all lanes.
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stimulate binding between Gpa1 and the dimerization deficient Arr4CCTT mutant (Figure 4.3
A), consistent with the established evidence that copper binding induces dimerization. These
data together show that dimerized Arr4 activates Gpa1-mediated signaling, and interacts with
Gpa1 in a direct, subtype-selective, and GDP-dependent manner consistent with known
GEFs.
Arr4 stabilizes nucleotide-free Gpa1
GPCRs are known to bind to and stabilize the nucleotide-free form of G? proteins.
To determine if Arr4 can perform this function, we resolved purified Arr4 and Gpa1 by
steric-exclusion chromatography. Proteins were detected by absorbance, by immunoblotting,
and by protein staining (Figure 4.4, and data not shown). In the presence of copper, Arr4 and
Gpa1 co-eluted with a mass corresponding to that predicted for the Arr4-dimer/Gpa1
complex at a 2:1 stoichiometry. This complex was disrupted by the addition of excess GDP,
yielding two distinct peaks: one at the predicted mass of Gpa1 and another corresponding to
dimerized Arr4. The Arr4 dimer was further dissociated by the removal of copper (Figure
4.4). These results demonstrate that Arr4 dimer binds stably to the nucleotide-free form of
G?.
Arr4 promotes nucleotide exchange on Gpa1 in vitro
In the absence of a GEF, the rate-limiting step in the G protein nucleotide cycle is the
release of GDP (53). A GEF accelerates GTP binding by stabilizing the nucleotide-free state
of G?, thereby promoting GDP release. Using purified components, we found that a 2:1
molar ratio of Arr4 to Gpa1 accelerates the rate of GTP binding, from 0.085 pmol to 0.36
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Figure 4.4
Figure 4.4  Arr4 forms a stable complex with Gpa1 that can be disrupted with
excess nucleotide. 4 mg of 6xHIS-Arr4 and 2 mg of 6xHIS-Gpa1 were combined and
resolved by steric-exclusion chromatography in the presence or absence of excess
GDP and CuSO4, as indicated. Note that the void volume elutes 200 minutes after
sample loading. Top panel, A260nm chromatogram. The peak of UV absorbance in the
void volume is evidently due to a non-protein buffer component, as determined by
Coomassie staining as well as by immunoblotting with penta-His antibodies. Bottom
panels, immunoblots using penta-HIS antibody. 20 ml of each 7 ml elution fraction
were loaded and resolved by SDS-PAGE. All data are representative of 3 separate
experiments.
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pmol GTP?S?pmol Gpa1-1?min-1 (Figure 4.5 A). This is comparable to the GEF activity
reported for Ric-8a (1, 151) (the GEF activity of the receptor Ste2 has never been quantified).
In the absence of copper Arr4 had almost no effect on GTP?S binding to Gpa1 (Figure 4.5
B). Arr4 alone, with or without copper, could not itself bind GTP?S (Figure 4.5 A and B).
Because GEFs function at the rate-limiting step in the GTPase cycle, accelerating
nucleotide exchange should also increase the rate of GTP hydrolysis. As a second measure of
Arr4 GEF activity, we showed that Arr4 accelerates the rate of [32P]GTP hydrolysis, from
0.009 to 0.021 pmol Pi?pmol Gpa1-1?min-1 (Figure 4.5 C). Arr4 itself, with or without copper,
could not hydrolyze GTP. We also purified a related human protein (hAsna-I) (84), but
detected no GEF activity towards Gpa1, G?i or G?s (data not shown).
Arr4 promotes pheromone signaling in vivo
To determine the role of Arr4 in GPCR signaling, we used three measures of pathway
activity: MAPK activation, gene transcription, and mating. Pheromone is known to stimulate
a downstream kinase cascade consisting of Ste11, Ste7, and the partially redundant MAPKs
Fus3 and Kss1. To determine if Arr4 modulates this response pathway, we first measured
phosphorylation of Fus3 and Kss1 using a phospho-MAPK specific antibody. As shown in
Figure 4.6 A, basal and pheromone-induced MAPK activation was substantially diminished
in arr4 mutant cells. We also tested salt stress-dependent activation of another MAPK, Hog1.
In this case we found no difference between wild-type cells and mutant cells that lack ARR4
(Figure 4.6 B).
Activation of the MAPKs Fus3/Kss1 results in selective induction of genes, such as
FUS1. To further confirm that Arr4 is a component of the mating-response pathway, we
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Figure 4.5
A
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Figure 4.5  Arr4 is a GEF for Gpa1.  (A) and (B) Time-course of [35S]GTP?S binding to
100 nM purified 6xHIS-Gpa1 in the presence of 200 nM GST-Arr4. Results are the mean ±
SEM of duplicate samples, and are presented as percent of maximum bound (saturated
binding occurred between 50-75%).  (A) with 500 nM CuSO4 added. (B) Same as in (A), but
no copper added to the reaction.  (C) Time-course of Pi  released from [
32P]GTP in the
presence or absence of 6xHIS-Gpa1 (250 nM), GST-Arr4 (500 nM), and copper (500 nM).
Results are the mean ± SEM of duplicate samples.
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measured transcription of mating-specific genes using the highly selective FUS1-lacZ
transcription reporter. Compared to wild-type, deletion of ARR4 caused a ~ 50% decrease in
pheromone-induced transcription (Figure 4.6 C). Finally, to determine directly if Arr4
contributes to cell fusion, we measured mating efficiency of MAT? cells with wild-type
MATa cells or MATa cells that lack ARR4. When compared to wild-type, arr4 mutant cells
were ~40% less likely to mate successfully (Figure 4.6 D). The observed decrease in mating
efficiency indicates that Arr4 contributes to mating, but is not essential for this activity.
Deletion of other pathway modulators that bind Gpa1, such as the effector protein Vps34 and
the RGS protein Sst2, exhibit a comparable degree of mating impairment (21, 22, 136). The
observed reduction in mating mirrors the reduction in MAPK and transcription-reporter
activities, and further establishes Arr4 as a positive modulator of the mating pathway.
DISCUSSION
For more than 20 years the yeast pheromone-response pathway has served as a model
system for G protein signaling (41). For the last decade, our understanding of the proteins
involved in this pathway has remained relatively unchanged. Here, we report the discovery of
a novel activator of yeast mating, one operating upstream of the G protein in conjunction
with cell surface pheromone receptors. Specifically, we find that Arr4 binds directly to the
G? subunit Gpa1 and induces nucleotide exchange. Arr4 binds as a dimer, since the
stoichiometry of the Arr4-Gpa1 complex is 2:1. Binding is selective, since Arr4 co-
precipitates with Gpa1 but not Gpa2. Binding is stable, since the complex can be resolved by
steric-exclusion chromatography. Binding appears to be ligand-dependent, since the complex
is dissociated by removal of copper. Most of these behaviors are characteristic of known
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Figure 4.6 Arr4 is necessary for maximal transmission of the mating signal. (A) Top
BY4741 or BY4741-derived cells lacking the ARR4 gene were treated with 3 µM ?-factor
mating pheromone and samples were removed at times indicated. MAPK activation was
determined by immunoblotting using a phospho-p44/42 MAPK antibody. Pgk1, loading
control.  Bottom As above, however, cells were treated with 500 mM KCl, and MAPK
activation was determined using a phospho-p38 MAPK antibody.  (B) Cells as in (A) were
transformed with pRS423-FUS1-lacZ, and treated with the indicated concentrations of
mating pheromone for 90 mins. Results are the mean ± SEM for 3 individual experiments
each performed in triplicate.  (C) DC17 MAT? cells were mixed with BY4741 (wild-type
MATa cells), arr4 deletion, or ste7 deletion as a control. Mating was performed by co-
incubation of cells on nitrocellulose filters. Maximum mating efficiency of the wild-type
cells was approximately 75%. Percent mating efficiency was calculated as number of
diploids/total number of MATa cells. Data are mean ± SD of 3 separate experiments.
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GPCRs, including the pheromone receptor Ste2. Finally, using complementary assays of
mating pathway activation, we find that Arr4 promotes Fus3 (but not Hog1) MAPK
activation, promotes Fus3-mediated gene induction, and enhances mating efficiency. Again,
all of these behaviors are characteristic of pheromone receptor activation. Taken together, our
results suggest that Arr4 functions as a GEF for Gpa1, and this GEF activity serves to
amplify the pheromone-response pathway.
It is worth emphasizing that all of the bioassays used here are highly specific for the
mating pathway. Fus3 and the transcription reporter FUS1-lacZ are activated only in mating-
competent haploid cells, and only upon stimulation by mating pheromones. Neither response
occurs in the absence of a functional G protein. While it is conceivable that Arr4 has
additional functions in the cell, Arr4 clearly binds selectively and directly to Gpa1, and loss
of this binding has significant consequences for the pheromone response. Moreover,
comparable differences were observed for MAP kinase activity, transcription induction, and
mating efficiency. Such differences are likely to be especially important in non-ideal (non-
laboratory) growth conditions.
Arr4 binds preferentially to the nucleotide-free form of Gpa1, although binding can
still be detected for the GDP-bound form of the protein.  Other cellular proteins, such as G??,
may further modulate the nucleotide-dependence of binding. Our working model, fully
supported by the data, is that Arr4 acts after dissociation of G protein subunits, and thereby
sustains the signal. Alternatively, Arr4 could function like Ric-8a to promote GTP binding to
Gpa1 directly, in the absence of bound G??. This model seems plausible considering that G?
expression was estimated to be ~2-fold higher than that of G?? (59). Moreover, we have
shown that Arr4 binds stably to G? in the absence of G?? (Fig. 2). Other possibilities are that
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Arr4 activates the G protein heterotrimer in cooperation with pheromone receptors, or
competes with G??  for binding to G? . Testing these more complex models will be
challenging, since they require the ability to express and purify functional receptor and G??.
Another open question is how Arr4 is itself regulated, and whether Arr4 is activated
by any internal or external stimulus. Arr4 was originally named because of its resemblance to
bacterial ARsenicals Resistance proteins. More recently, the ARR4 gene was implicated
through hierarchical clustering analysis to be involved in ER/Golgi trafficking, and renamed
GET3 (131). ARR4/GET3 was also shown to function as an extragenic suppressor of npl4,
encoding a component in the ubiquitin-proteasome system (8). Gpa1 is ubiquitinated, but a
role for Gpa1 activation in its ubiquitination has not been established (94). Another
possibility is that Arr4 is dynamically regulated by copper. In fact, Arr4 has been reported to
localize to the cytoplasm but then translocate to punctate intracellular structures when cells
are stressed with heat and/or metal ions (132). The effect of these stresses on copper
homeostasis is not known however. Regardless, Gpa1 is expressed on the cytoplasmic face of
the plasma membrane and would therefore be fully accessible to Arr4 in vivo.
Identification of non-receptor exchange factors has been difficult, as no signature
sequence or domain exists that accurately predicts activity. Indeed, there is no sequence
similarity and no common predicted fold among receptor and non-receptor GEFs. Here we
have identified a novel GEF based on its preferential binding to the Gpa1N388D mutant. Our
data suggest that analogous mutations in other G? proteins could be used to identify GEFs in
other systems as well. Our genetic studies in yeast reveal a critical role for Arr4 signaling in
vivo, and suggest further that non-receptor GEFs may be more common and have a broader
physiological function than previously appreciated.
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EXPERIMENTAL PROCEDURES
Strains and plasmids—Standard methods for growth, maintenance, and
transformation of yeast and bacteria and for the manipulation of DNA were used throughout.
Yeast Saccharomyces cerevisiae strains used in this study were BY4741 (MATa  leu2?
met15? his3? ura3?), BY4741-derived mutants constructed using the KanMX G418-
resistence marker (Yeast Deletion Clones, Invitrogen; originally purchased from Research
Genetics), BY4741-derived strains containing a C-terminal tandem affinity purification
(TAP) tag (Yeast TAP-Fusion Library, Open Biosystems), and DC17 (MAT? his1). The
arr4? strain from Research Genetics did not produce a phenotype that could be rescued by
addition of a plasmid-borne copy of ARR4, so the strain was remade by PCR amplification of
the original deletion cassette and transformation of the parent strain.
Yeast shuttle plasmids used were pRS305 (ampR, LEU2) and pAD4M (2µm, ampR,
LEU2, ADH1 promoter and terminator). Expression plasmids described previously were
pAD4M-GPA1 (139), pAD4M-GPA1Q323L (62), pRS423-FUS1-lacZ (74). The pAD4M-
GPA1N388D plasmid was created using the QuikChange Site-Directed Mutagenesis Kit
(Stratagene) and mutagenic primer 5’-CG TTC AGA ACG CAG GCC TCC AGC GTC GA-
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3’ and its complement. pAD4M-ARR4 was constructed by PCR amplification of BY4741
genomic DNA, followed by XmaI and SalI digestion, and ligation into the corresponding
sites of pAD4M. Primers used were: forward 5’-TCC CCC GGG GGA CGT ACG ACA
AGA ACA AGA AGA TC-3’ and reverse 5’-CGC GTC GAC GTC CTG AGC TGG GCT
TAT TAC TTC GTT GC-3’. The pRS305-ARR4 plasmid was created using a similar
method; however, the forward primer amplified a region beginning approximately 600 bp
upstream of the start ATG (forward primer sequence: 5’-TCC CCC GGG GGA GCA TCA
TCC TTT CCC ACA TTT GAT G-3’). The arr4CCTT mutations were created using
QuikChange and mutagenic primer 5’-GAT CAA GAG CAC AAC ACT AAG AGA ACT
CAG GCA AGA TGG AAG ATG-3’ and its complement.
Screen for candidate Gpa1-binding partners from yeast— To identify candidate
GEFs, we considered 27 proteins reported to bind to the yeast G? subunit Gpa1. This list was
compiled from published genome-wide yeast-2-hybrid screens, protein co-purification
screens, as well as unpublished data from our laboratory (76, 83). The first criterion for
candidate GEFs was nucleotide-dependent interaction with the G protein. We have shown
previously that the GPCR Ste2 (even in the absence of pheromone) binds more tightly to
Gpa1N388D than to the wild-type form of the G protein (171). Plasmids pAD4M, pAD4M-
GPA1, pAD4M-GPA1Q323L, or pAD4M-GPA1N388D were transformed into yeast strains
expressing TAP-tagged fusions of candidate Gpa1-binding proteins. Purification of TAP
fusions was performed as described previously (136). Briefly, cells were grown to mid-log
phase in selective media, and harvested by centrifugation at 3,000 x g. The remaining steps
were performed at 4° C. Cell pellets were resuspended in lysis buffer (50 mM NaPO4 pH 7.5,
400 mM NaCl, 0.1% Triton X-100, 10% glycerol, 0.5 mM DTT, 25 mM NaF, 25 mM 2-
120
glycerophosphate, 1 mM NaVO3, 5 mM PMSF, and one pellet per 50 ml buffer of complete
EDTA-free protease inhibitor cocktail (Roche Applied Science)). (buffer composition
indicates final concentrations). Cells were disrupted by vortexing with glass beads 8 x 30 s
with 1 min of cooling on ice in between. Lysates were centrifuged at 6,000 x g for 5 min and
again for 25 min, and the resulting supernatant was mixed with Calmodulin Affinity Resin
(Stratagene). Cells were rotated at 4° C for 2 h, and washed 4 times with 1 ml of lysis buffer.
Bound protein was eluted in 2x SDS-PAGE sample buffer at 65° C for 5 min. Samples were
resolved by 8% SDS-PAGE and immunoblotting with anti-Gpa1 polyclonal antibodies at
1:1000 for 2 h, and visualized using horse radish peroxidase-conjugated secondary antibodies
and chemiluminescence detection.
E. coli expression of GST- and 6xHIS fusion proteins—6xHIS-Gpa1 expression
plasmid was described previously (4). Plasmids for bacterial expression of GST-Arr4 and
6xHIS-Arr4 fusion protein were generated by ligation-independent cloning as described
previously (143). ARR4 was PCR-amplified from genomic DNA (Forward primer: 5’—TAC
TTC CAA TCC AAT CGC ATG GAT TTA ACC GTG GAA CC—3’; reverse primer:
5’—TTA TCC ACT TCC AAT GCG CTA CTA TTC CTT ATC TTC TAA CTC—3’),
annealed to the gapped 6XHIS vector pMCSG7 or a version of pMCSG7 modified to contain
a GST tag (from Jason Snyder and John Sondek, Univ. North Carolina), and transformed into
BL21 (DE3) E. coli. Overnight cultures from single colonies grown at 37°C in Luria Broth
(LB) supplemented with 100 µg/ml carbenicillin were diluted 1:100 into fresh media and
grown to A600 nm ~ 0.7. 6xHIS-Gpa1 and 6xHIS-Gpa2 expression was induced by addition of
0.1 mM isopropyl ?-D-1-thiogalactopyranoside and incubation at room temperature for 5 h
with shaking. GST-Arr4 was induced by addition of 0.1 mM isopropyl ? -D-1-
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thiogalactopyranoside and incubation at 18°C for 14 h. Cells were harvested by
centrifugation, resuspended in Buffer A (20 mM Tris pH 8.0, 200 mM NaCl, 5% glycerol, 1
mM DTT), and homogenized using an Emulsiflex-C5 Homogenizer (Avestin Inc.). Lysates
were clarified by centrifugation at 12,000 x g  for 30 min and the resulting supernatant was
mixed with Glutathione-Sepharose 4B resin (Amersham Pharmacia Biotech AB) equilibrated
with Buffer A, and incubated for 2 h at 4°C with gentle rotation. Resin was collected by
centrifugation at 500 x g  for 5 min and washed 3 times in Buffer A, 10 mM reduced
glutathione. Elution was concentrated using Vivaspin concentrators (Vivascience AG).
In vitro co-precipitation of GST fusion proteins—6xHIS-Gpa1 was equilibrated in
binding buffer (20 mM Tris pH 8.0, 150 mM NaCl, 0.1% Triton, 1 mM EDTA, 2 mM
MgCl2, 1 mM DTT, 10 µM GDP) for 20 min at 16°C. GST-Arr4 was added, and allowed to
incubate at 16°C for 20 min with gentle mixing. Samples were then mixed with 50 ml of a
50% slurry of Glutathione-Sepharose 4B resin equilibrated with binding buffer. The total
volume of the reaction was 500 µl. Protein was incubated in the presence of GST resin for 1
h, then centrifuged at 500 x g , and washed three times with binding buffer for 10 min each.
Bound proteins were eluted with 10 mM reduced glutathione in binding buffer and resolved
by 10% SDS-PAGE, and immunoblotting with penta-HIS antibody (Qiagen), Gpa1
polyclonal antibody or GST antibody (from Joan Steitz, Yale University) (all at 1:1000).
Steric-exclusion chromatography—Purified protein was subject to steric-exclusion
chromatography using an Akta FPLC system and a Sephacryl 26/60 S200 column (GE
Healthcare). Protein was equilibrated in 20 mM Tris pH 8.0, 100 mM NaCl, 5% glycerol, 1
mM DTT, 2 mM MgCl2, 20 µM GDP (when added), and 150 nM CuSO4 (when added).
Protein was separated at 0.5 ml/min, and collected in 7 ml fractions. UV absorbance of each
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fraction (A280nm) was recorded and data analyzed using the UNICORN program associated
with the FPLC system. A 20 µl sample from each fraction was separated by SDS-PAGE and
either probed with penta-HIS antibody or stained with Coomassie Brilliant Blue R250 (Bio-
Rad).
 GTP binding assay—GTP?S binding was measured using a filter binding method, as
previously described (4). Briefly, purified proteins were diluted to desired concentrations in
assay buffer (50 mM HEPES pH 8.0, 1 mM EDTA, 0.1% C12E10, 1 mM DTT, 2 mM MgCl2,
2 µM GTP?S), and reactions initiated by addition of [35S]GTP?S at 20°C (2,000 cpm/fmol;
Perkin Elmer). Duplicate aliquots were removed at timed intervals, and quenched by addition
of ice-cold stop buffer (20 mM Tris pH 7.4, 125 mM NaCl, 25 mM MgCl2). Quenched
reactions were passed through nitrocellulose membranes using vacuum and washed 4 times
with ice-cold stop buffer. Non-specific binding was determined in parallel reactions by
addition of 100-fold excess of unlabelled GTP?S to the reactions. Binding was quantified
using liquid scintillation counting.
Steady state GTP hydrolysis assay—Steady state GTPase reactions were performed as
described previously (4). Briefly, purified proteins were diluted as in the GTP binding assay
and reactions initiated by addition of an equal volume of assay buffer containing [?32P]GTP
(2,000 cpm/fmol; Perkin Elmer). Duplicate aliquots were removed at timed intervals and
quenched with ice-cold activated charcoal in 20 mM phosphoric acid. Charcoal was
separated by centrifugation, and the supernatant subjected to scintillation counting to
quantify released [32P]Pi. Background was determined in parallel reactions in the absence of
Gpa1, and background values were subtracted to determine specific Pi produced.
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MAPK phosphorylation assays—Yeast strains were grown with shaking at 30°C in
selective media to A600 nm ~0.8 and treated with either 3 µM ?-factor pheromone or 500 mM
KCl. Samples were removed at timed intervals, collected by centrifugation, and stored at -70°
C. To prepare extracts, cell pellets were thawed on ice and resuspended in 250 µl of ice cold
TCA buffer (10 mM Tris pH 8.0, 10% trichloroacetic acid, 25 mM NH4OAc, 1 mM EDTA).
Cells were disrupted by vortexing with 100 µl of glass beads in 5 x 1 min bursts with chilling
on ice in between. Lysates were transferred to new tubes and centrifuged for 10 min at
16,000 x g at 4°C. Pellets were resuspended in 0.1 M Tris pH 11.0, 3% SDS, and boiled for 5
min, then centrifuged at 16,000 x g. The resulting supernatant was separated and protein
concentration was determined using the DC protein assay (Bio-Rad Laboratories). 20 µg of
protein in 2x SDS-PAGE sample buffer was used per time point. MAPK phosphorylation
was determined by 12% SDS-PAGE and immunoblotting with p44/42 MAPK antibody or
p38 MAPK antibody at 1:500 (Cell Signaling Technology). Densitometry of developed blots
was determined using ImageJ. The MAPK signaling defect in arr4 cells was rescued by a
plasmid-borne copy of ARR4 (data not shown).
Transcription reporter assay—Cells were transformed with pRS423-FUS1-lacZ, and
?-galactosidase activity was determined as described previously (74). Briefly, cells were
grown to A600 nm ~ 0.8, and treated with ?-factor mating pheromone for 90 min. 1 mM
fluoro-di-D-galactopyranoside (FDG) diluted in 25 mM PIPES pH 7.2 was added, and cells
were incubated at 37°C in the dark for 45 min. Reaction was quenched by addition of
Na2CO3 to a final concentration of 200 µM and fluorescence at 485-530 nm was measured
using a VersaMax optical plate reader. The transcription-reporter defect in arr4 cells was
rescued by a plasmid-borne copy of ARR4 (data not shown).
124
Mating assay—Yeast mating efficiency was determined using the filter method, as
described previously (140). Briefly, cells were grown in YPD to A600 nm ~ 0.8. 2 x 10
6 
MATa
cells (counted using a hemacytometer) were mixed with 2 x 107 MAT? cells in a volume of
15 ml, and the mixture was passed through a nitrocellulose filter (Millipore). Filters were
incubated cell side up on YPD agar plates for 5 h, and resuspended into water. Serial
dilutions were spread onto selective media plates, and diploids counted after 3 days. The
mating defect in arr4 cells was rescued by a plasmid-borne copy of ARR4 (data not shown).
CHAPTER V
Conclusions and Future Directions
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Heterotrimeric G proteins and their associated receptors are arguably the most
medically relevant signaling proteins in human physiology.  Without question, targeting
these systems for the creation of new drugs has been among the biomedical community’s
most common—and most successful—efforts.  It is self evident then, that an increased
understanding of how heterotrimeric G protein signaling is regulated will result in an
increased ability to target these systems for therapeutic benefit.
In the last half-decade, one emerging trend in the field is the possibility that G
proteins signal at intracellular sites.  Before we can fully appreciate how the cell utilizes
intracellular signaling by G proteins, a number of basic questions need to be addressed.  For
example:  are intracellular signals being transmitted by activated (and subsequently
translocated) pools of plasma membrane G protein or by intracellular pools of G protein?
How does the G protein traffick and specifically localize in the cell?  How is localization
regulated? What role is played in intracellular signaling by GPCRs?  What role is played by
non-receptor GEFs?  What is the benefit to spatially distinct signaling?  In an effort to answer
some of the basic questions related to intracellular signaling, I have addressed two questions:
1) what are the factors that regulate the membrane localization and internalization of Gpa1
(ChapterII and III), and 2) does a non-receptor activator exist in yeast to activate Gpa1
(Chapter IV)?  In this chapter, I will briefly review the major findings presented in this thesis,
discuss the implications of these findings, present some unfinished data for each of the major
aims, and discuss the future directions of this work.  Of particular interest will be the
crystallization trials for Gpa1, Arr4, and the two-protein complex; preliminary investigation
of the role of the de-palmitoylating enzyme Apt1; and a detailed discussion about the value
of the dominant negative mutant Gpa1N388D.
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REGULATION OF GPA1 PALMITOYLATION
Presented in Chapter III of this thesis is the characterization of a novel tool for
screening proteins involved in Gpa1 palmitoylation.  Considering that the unpalmitoylated
mutant of Gpa1 has only minor signaling phenotypes, the genetic advantages of using the
yeast model system are not easily exploited.  Using the Gpa1G2A/2K mutant—a form of the G
protein that is unmyristoylated but has a short lysine stretch in its place—Gpa1
palmitoylation now is necessary for viability.
In addition to the screening potential of Gpa1G2A/2K, these findings also provide a
validation of the “two signal hypothesis” for membrane attachment.  It had previously been
proposed that stable association with the plasma membrane required two membrane
anchoring signals (some combination of lipid modifications, interaction with a
transmembrane protein, basic patch of amino acids, etc.).  For the most part, G? subunits
adhere to the two signal theory:  subunits with only 1 signal fall-off of the membrane when
activated (Gt for example), subunits with 2 signals remain stably associated with the
membrane.  In accordance with this theory, it was hypothesized that G? subunits that have
only 1 lipid modification must use a poly-basic patch as a second signal in order to reach the
plasma membrane, and this was recently found to be true (116).  Here by combining G2A
and a short poly-lysine mutation, we crippled one membrane anchor of Gpa1, creating a
protein that requires palmitoylation and G?? for membrane binding.
Screening for PATs   
The future directions of this project are to first test the known DHHC family members
for redundancy in activity towards Gpa1.  This will require that the genes be deleted in
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various combinations until inviable cells are found.  It is known that mispalmitoylation
requires deletion of 6 of the 7 known PATs (all except Swf1) (125). It remains a possibility,
however, that some specificity exists among these six PATs, because all permutations of the
remaining 6 genes have not been tested.  The next step will be to test the entire yeast genome
deletion collection for defects in Gpa1 palmitoylation.  This screen is likely to uncover
proteins involved in the trafficking of Gpa1 to relevant PATs, and potentially also new non-
DHHC PATs.  Both of these findings would be met with interest. The identification of PATs
is in its infancy, so screening for these enzymes using functional criteria, rather than simply
by homology is a reasonable endeavor.
Regulation of Gpa1 localization and function by the de-palmitoylating enzyme Apt1.
Acyl-Protein Thioesterase 1 (APT1) is a gene identified by Duncan and Gilman
because of its homology to a rat protein they had previously determined to function as a de-
palmitoylating enzyme (45).  Gilman’s group thought to look for an enzyme of this type
because of the increase in palmitate turnover following activation of many G? subunits.
Furthermore, it had been known for some time that, unlike N-myristoylation or
isoprenylation, palmitoylation is metabolically reversible.  The authors found that yeast Apt1
had the same function as rat Apt1 in vitro: it contained low lysophospholipase activity and
acyl-protein thioesterase activity (Apt1 preferred palmitoyl-G? over lysophospholipids by
several hundred fold).  Yeast then became a suitable host for answering the fundamental
question surrounding APT1: what is the purpose of regulated deacylation?  Unfortunately,
although the authors were able to show that Apt1 is exquisitely specific for G? subunits, they
found no phenotypes of the apt1? in the G? controlled yeast mating pathway (44).
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Figure 5.1 APT1 deletion does not result in defects in the mating response.  (A) BY4741
wild-type cells, and BY4741-derived cells lacking APT1 were grown to saturation, plated,
and exposed to paper discs containing various amounts of ?-factor pheromone (clockwise
from top right:  1.5, 4.5, 15, and 45 µg).  (B) Cells as in (A) were transformed with pRS423-
FUS1-lacZ, grown to mid-log phase and exposed to various concentrations of ?-factor for 90
minutes. Results are the mean ± SEM for 3 individual experiments each performed in
triplicate.  (C) Cells as in (A) were grown to mid-log phase and exposed to 3 µM ?-factor.
Cells were removed at timed intervals.  Extracts were resolved using 12% SDS-PAGE and
immunoblotting using phospho-specific p44/42 MAPK antibodies.
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As an extension of my work to identify PATs for Gpa1, I also wanted to revisit the
regulation of Gpa1 localization and/or function by Apt1.  In the five years since the studies
by Duncan and Gilman, the tools available for assaying mating pathway activation have
improved greatly both in sensitivity and in number.  So, we monitored mating pathway
activation at the level of pheromone-sensitivity (using the classic halo assay), MAPK
phosphorylation (using a phospho-specific p44/42 MAPK antibody), mating gene
transcription (using a FUS1-LacZ transcription reporter construct and the fluorescent reagent
FDG), and localization (using a Gpa1-GFP reporter in live cells).  Beginning with the
pheromone-sensitivity assay, as did Duncan and Gilman, we found no difference between
wild-type yeast cells and cells that lack apt1 (Figure 5.1 A).  In addition, using our more
refined assays for pathway activation, MAPK phosphorylation and gene transcription, we
also found no significant differences in apt1? cells (Figure 5.1 B, C).  The first clue of the
function of Apt1 came when we monitored Gpa1 localization using our Gpa1-GFP reporter
protein.  We found that in apt1? cells, Gpa1-GFP accumulated in intracellular puncta rather
then the plasma membrane (Figure 5.2 A).  This finding was unexpected, especially
considering that Gpa1
C3S
-GFP (a fluorescently tagged mutant that 0% palmitoylated, as
opposed to apt1? which is presumably 100% palmitoylated), is localized normally with
respect to wild-type (data not shown).
Our interpretation of Gpa1 localization in apt1? cells is that de-palmitoylation is
necessary either for delivery to the plasma membrane (during protein maturation) or for
clearance, following endocytosis.  If Gpa1 is being endocytosed, we would expect that the
mono-ubiquitinated form of Gpa1 would accumulate in apt1? cells.  To test this, we over-
expressed Gpa1 (to increase visibility of the mono-ubiquitinated form of the G protein) and
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probed cell lysates with a Gpa1-specific antibody.  This method was previously successful in
identifying both poly- and mono-ubiquitinated forms of Gpa1 (see Chapter II) (164).  We
found no accumulation of mono-ubiquitinated Gpa1 in apt1? cells, suggesting the puncta are
not en route to being degraded in the vacuole (Figure 5.2 B).
A number of possibilities need to be addressed before we can state with any certainty
what role Apt1 is playing in Gpa1 function.  Using co-localization with known compartment
markers in yeast, we will attempt to identify where Gpa1 is accumulating. Also, a question
that has not been addressed is if Apt1 regulates Gpa2, the other G?  subunit in yeast
(responsible for regulating responses to glucose) (108, 173).  Finally, using cell fractionation,
we can determine quantitatively how much G protein is present (if any at all) at the cell
periphery.  One of the interesting implications of Gpa1 localization in apt1? cells is that
pheromone dependent signals can transmit directly from intracellular sites.  In apt1? cells,
the vast majority of Gpa1 appears to be localized away from the plasma membrane, but
signaling remains normal.  If G?? were localized at the plasma membrane without Gpa1, we
would expect aberrant signal activation.  Since signaling remains normal, either G??
expression has been compromised or that G?? is localized along with Gpa1 at the
intracellular compartments; both of these possibilities will be tested.  Also, the fact that
pheromone signals can still be transmitted in apt1? cells suggests that the internalized
pheromone receptor is competent to transmit a signal.  Studies using fluorescent ? factor
(pheromone) show that the ligand remains bound to the receptor throughout the
internalization process (10), making signaling by the internalized receptor a formal
possibility.
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Figure 5.2 APT1 deletion cells mislocalize Gpa1-GFP.  (A) BY4741 wild-type cells and
BY4741-derived cells lacking APT1 were transformed with the integrating plasmid pRS406-
GPA1-GFP.  Cells were grown to mid-log phase, and visualized using a fluorescent
microscope.  (B) A high-copy over-expression plasmid (pAD4M) containing GPA1 was
transformed into BY4741, or cells lacking PEP4 or APT1.  Cell extracts were resolved by
7.5% SDS-PAGE and immunoblotting using anti-Gpa1 antibodies.  The presence of
myristoylated (myr-Gpa1), unmyristoylated (unmyr-Gpa1), and mono-ubiquitinated (mub-
Gpa1) species of Gpa1 can be seen as in Figure 2.1.
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GPA1 UBIQUITINATION: THE 110 AMINO ACID UBIQUITINATED SUB-
DOMAIN
One of the main findings in this thesis is that Gpa1 ubiquitination can result in
trafficking to the vacuole or degradation by the proteasome (see Chapter II).  Furthermore, I
provided evidence that the proteasomal degradation pathway regulates turnover of misfolded
protein, while mono-ubiquitination regulates vacuolar trafficking of functional, plasma
membrane localized, and myristoylated Gpa1.  The implication of this finding is that the
myristate moiety is recognized by the ubiquitination machinery and is necessary either for
stable ubiquitination or internalization, however, more work needs to be done to directly test
this hypothesis.
For future studies, we are interested in resolving the structure of Gpa1.  Gpa1 is
unique in that it contains a 110 amino acid extension in the all-helical domain that is not
conserved among other G? subunits. As detailed in this thesis, the 110-residue sub-domain
contains all residues necessary for ubiquitination of Gpa1.  Considering that this sub-domain
contains important regulatory elements, yet the structure remains unresolved, one of our
present and future efforts is to crystallize full-length Gpa1.  We have initiated Gpa1
crystallization trials in parallel with trials for Arr4, and for the Arr4-Gpa1 complex.  All of
these trials will be described below. 
CRYSTALLIZATION TRIALS: GPA1, ARR4, AND THE ARR4-GPA1 COMPLEX
In terms of receptor-mediated activation, the question remains: how do receptors act
at a distance to manipulate switch regions of G? subunits?  Our understanding of this process
will remain incomplete until the structure of a receptor in complex with G protein
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Table 5.1 Crystallization trials for Gpa1, Arr4, and Gpa1/Arr4 complex.  To date,
crystallization screening trials have focused on sparce matrix commercial screening kits from
Hampton Research and NexTal (Qiagen).  Some of the trials were performed robotically,
either at the Hauptman-Woodward Institute (HWI) or at the UNC Crystallization Core
Facility (Rigaku UNC).  Trials at HWI were performed using the microbatch under oil
technique; trials performed at the UNC core facility were performed using a Rigaku robot
utilizing the sitting drop technique.  The rest of the trials were performed manually using
hanging drops.
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heterotrimer is resolved.  Although many lines of evidence suggest that activation by non-
receptor GEFs is likely by a different mechanism than that of receptors, understanding
activation by non-receptor GEFs is also an important question.  Considering that we recently
identified a non-receptor GEF for the yeast G? subunit Gpa1, one of our highest priorities is
to solve the co-crystal structure of the GEF/G protein in complex.  As mentioned above, we
are also interested in solving the structure of Gpa1 alone, because of the functional
importance of 110 amino acid sub-domain in ubiquitination and trafficking.
Our first task when attempting to crystallize Arr4 and Gpa1 was to purify both
proteins to greater than 95% purity.  Using 6xHIS-tagged proteins, we were able to obtain
pure protein through a procedure involving nickel-affinity purification in conditions of high
salt (400 mM NaCl), tobacco etch virus (TEV) protease cleavage of the 6xHIS tag (and
subsequent binding of cleaved 6xHIS tag to Ni- affinity resin), and finally size exclusion
chromatography (S200) (Figure 5.3).  Each of these steps was critical to protein purity, and
the final protocol evolved after a number of trials.
Once we obtained high-purity protein, we next needed to identify conditions that
support stable Arr4 dimerization and stable Arr4-Gpa1 complex formation.  We and others
identified that Arr4 functions as a dimer, and that copper facilitates dimerization (101).
Using size exclusion chromatography, we found that the vast majority Arr4 protein migrates
as a dimer in the presence of copper (Figure 5.4).  Furthermore, as shown in Chapter IV,
incubating Arr4 and Gpa1 in the absence of GDP (and presence of copper) allowed for stable
complex formation between the Arr4 dimer and Gpa1 (see Chapter 4).
139
Target
Protein
H HH
HH
H
bead
I
II
I
I
I
I
I
I I
I
I
I
bead
H HH
HH
H
Target
ProteinH HH
HH
H TEV
bead
Target
Protein
H HH
HH
H
Target
Protein
H HH
H H
H
Target
Protein
H H
H H
H
Target
Protein
H HH
HH
H Target
Protein
H HH
H H
H
Target
Protein
H HH
H H
H
Target
Protein
H HH
H H
HTarget
Protein
H HH
H H
H
Target
Protein
H HH
HH
H
Target
Protein
H HH
H H
H
Target
Protein
H HH
H H
H
Target
Protein
H HH
HH
H
Target
Protein
H HH
H H
H
s200
Figure 5.3
1    2    3   4   5   6   7  8  9  10  11 
1    2   3    4   5    6   7   8    9   10 11
A
B
C
Gpa1
Arr4
140
Figure 5.3 Purification of Gpa1 and Arr4 for crystallization.  (A) Gpa1 and Arr4 were
purified for crystallography using affinity purification using 6xHIS tagged protein and Ni-
NTA resin; cleavage of the affinity tag followed by separation of uncleaved protein (as well
as non-specific binding proteins); size-exclusion chromatography using an S200 gel filtration
column (Amersham).  (B) Coomassie stained gel showing various stages of Gpa1
purification.  Gpa1 was purified to single band purity using the method described in (A).
lane 1 6xHIS Gpa1 before TEV cleavage; lane 2 Gpa1 following TEV cleavage and binding
to Ni-NTA resin; lanes 3-11 S200 fractions.  Fractions 8-10 were collected and concentrated.
6-10 mg of Gpa1 was purified from 4 liters of bacterial culture.  (C) Coomassie stained gel
showing various stages of Arr4 purification.  Gel loaded as in (B).  Fractions 7-9 were
collected and concentrated.  25-35 mg of Arr4 was purified from 4 liters of bacterial culture.
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Having established conditions for the expression and purification of Gpa1 and Arr4,
we then focused on screening to identify conditions that support crystal formation.  For our
initial screening trials, we utilized four different commercial kits, with the goal of testing a
wide array of salts, buffers, and precipitants (Table 5.1).  We also varied temperature and
protein concentration, all while using the hanging drop method of crystallization (12).  In this
initial screening, we were unable to identify any crystal forming conditions for Arr4 alone, or
Arr4-Gpa1 complex, but did find a condition that supported crystal formation of Gpa1 alone
(data not shown).  The crystals formed were thin, long, rods.  Upon manipulation, they
appeared to be protein, not salt, however, “defraction quality” crystals were not obtained.
Attempts to screen around this condition were not successful.
Hauptman-Woodward Institute, Buffalo NY—We have also utilized a fee-for-service
high-throughput crystallization screening facility at the Hauptmann-Woodward Institute
(HWI) in Buffalo, NY.  We were not limited by protein abundance, and felt the trials
performed by HWI would complement those we were performing manually.  HWI uses a
robotic crystal-screening device to set up 1600 separate conditions of a particular test protein
using the microbatch under oil crystallization method.  This method is significantly different
than other popular methods that rely on vapor diffusion, such as hanging drop and sitting
drop.  The 1600 conditions tested by HWI represent a wide array of salts, buffers,
precipitants, PEGs, and 9 commercial kits produced by Hampton Research (Table 5.1).  All
trays are set up at room temperature, and protein is typically used at a concentration of 10
mg/ml.
Our crystallization trial yielded a number of potentially interesting hits for Arr4
alone, but not Gpa1 alone or Arr4-Gpa1 complex.  We found 4 different conditions that
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Figure 5.4
Figure 5.4  Efficient dimerization of Arr4 in the presence of copper.  Purified Arr4
protein was separated using an S200 gel filtration column in the presence of CuSO4.  3
peaks are visible (as labeled): void (likely containing aggregated or insoluble protein),
Arr4 dimers, and Arr4 monomers (column size calibration not shown).
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Figure 5.5
A B
C D
Figure 5.5  Preliminary Arr4 crystals.  Crystallization trials were performed using
purified Arr4 (10 mg/ml) at the HWI high-throughput crystallization screening facility
in Buffalo, NY.  All trials were performed using the microbatch under oil method.
Pictures were taken 24 hours after drop set-up.  Conditions were (A) 0.1 M
Ammonium Nitrate; 0.1 M HEPES (pH 7.5); 40 % PEG 4000; (B) 1.0 M Lithium
Chloride; 0.1 M HEPES (pH 7.0); 30 % PEG 6000; (C) 0.2 M Sodium Chloride; 0.1
M bis-Tris (pH 6.5); 25 % PEG 3350; (D) 0.2 M Ammonium Acetate; 0.1 M bis-Tris
(pH 5.5); 25 % PEG 3350.
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supported crystal formation of Arr4 (Figure 5.5).  All crystals formed between 0-24 hours.
All conditions contained PEG as a precipitant, and all conditions were neutral in pH (5.5-
7.5).  Our initial attempts to reproduce these crystals using hanging drops were unsuccessful
(data not shown).  Subsequent attempts using the microbatch technique also did not yield
crystals, but these trials were set up with a different preparation of protein, so minor
differences in protein composition may have led to these differences.
 Rigaku robot trials, Crystallization Core Facility, UNC—Our most recent
crystallization trials were conducted at the Crystallization Core Facility at the UNC at Chapel
Hill with assistance from Dr. Laurie Betts and Dr. Janeen Vanhooke.  These trials were
robotically performed utilizing a sitting drop technique, and we began by screening three
different commercial kits across two different temperatures and two different protein
concentrations (Table 5.1).  These trials were begun very recently, and to date, no crystals
have formed.
LOCALIZATION OF ARR4 IN PHEROMONE TREATED CELLS
Presented in this thesis is the discovery that Arr4 functions as a non-receptor GEF for
Gpa1 (see Chapter IV).  We found using purified components that the Arr4 functions in a
manner that is similar to that of GPCRs, and also that Arr4 activity promotes the yeast
mating response.  Our conclusion is that Arr4 does not initiate the signal, and cannot
functionally replace the receptor, but is necessary for maximum signal amplification.  It is
still unclear, however, where Arr4 functions, particularly given our previous findings that
Gpa1 exists at multiple cellular compartments and signals from both the plasma membrane
and endosomes.  At least three possibilities exist: Arr4 could function immediately
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downstream of the GPCR Ste2 at the plasma membrane, Arr4 could activate Gpa1 at
endosomes, or Arr4 could function at a yet unidentified compartment. Here, I will present
preliminary data addressing these possibilities.
Vps34 is required for Arr4-mediated activation of Gpa1
Following our discovery that Arr4 activates Gpa1, we first wanted to determine if
Arr4 contributes to endosomal signaling.  Arr4 is generally considered to exist at the
endoplasmic reticulum (ER), but also has been shown to exist at late endosome (132).  We
have previously determined that over-expressed ARR4 results in mating pathway activation
through Gpa1 (see Chapter IV) (88).  To determine if Arr4-induced pathway activation
occurs at the cell periphery or at the cell interior, we tested whether pathway activation
requires Vps34, the endosomal effector of Gpa1.  As shown previously, in the wild-type
genetic background, ARR4 over-expression caused a nearly 4-fold increase in basal pathway
activation.   Using a FUS1-LacZ transcription reporter, we found that ARR4 over-expression
had no effect on pathway activation in vps34? cells (Figure 5.6 A). These data suggest that
Arr4 signaling requires Vps34, and potentially, that Arr4 functions as an intracellular GEF
for Gpa1.
Arr4 translocates to intracellular puncta upon treatment with mating pheromone
Having found evidence that Arr4 contributes to endosomal signaling, we next wanted
to determine if Arr4 exists at the endosome.  To answer this question, we created a GFP-
tagged version of Arr4 and monitored its localization in cells treated with and without mating
pheromone.  We found, as reported by others, that Arr4 appears throughout the cytoplasm,
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with slight enrichment in ER regions (Figure 5.6 B).  However, when treated with mating
pheromone, Arr4 became localized to very distinct, very bright intracellular puncta (Figure
5.6 B). These puncta were not morphologically consistent with what we had previously seen
as endosomes, and did not co-localize with a marker for the endosomal compartment Snf7-
RFP (Figure 5.6 B).  Although Arr4 does not reside at the endosome, it is still possible that
Arr4 contributes to endosomal signaling.  In addition, these data provide further evidence
that Arr4 is responsive to pheromone, and provide the first evidence that Arr4 functions from
an intracellular location.
Identification of Arr4 localization using mass spectrometry
Using microscopy of live cells, we were able to determine that Arr4 resides at an
intracellular location upon treatment with pheromone, but we were not able to identify that
location.  Rather than attempting co-localization with a larger panel of compartment markers,
we decided to purify Arr4 from yeast and identify all co-purifying bands using mass
spectrometry.  Identification of pheromone-dependent binding partners could give us clues to
the localization of Arr4 and also give insights into Arr4 regulation and function.
Using a FLAG-tagged version of Arr4, expressed at endogenous levels behind its
native promoter, we purified Arr4 in the presence and absence of pheromone.  Arr4
containing a myc tag, rather than FLAG tag, was used as a negative control. A small portion
of the eluant was analyzed by silver stain and also immunoblotted with anti-FLAG antibody,
and the rest analyzed by Orbitrap liquid chromatography/mass spectrometry (LC/MS).  Silver
stain analysis showed that Arr4 purification was relatively clean (not many co-purifying
bands), however, at least one pheromone-dependent interaction was detected (Figure 5.7 A).
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Figure 5.6  Evidence that Arr4 regulates Gpa1 from an intracellular location.  (A)
BY4741 or BY4741-derived cells lacking VPS34 were transformed with a high copy vector
(pAD4M) containing ARR4 (or empty vector).  Cells were also transformed with the reporter
plasmid pRS423-FUS1-lacZ.  Data are basal ?-galactosidase activity; Results are the mean ±
SEM for 3 individual experiments each performed in triplicate.  (B) BY4741 cells were co-
transformed with integrating plasmids pRS406-GFP-ARR4 and pRS403-SNF7-RFP
(endosomal marker protein).  Cells were treated with 3 µM ?-factor for 90 minutes and
visualized using a fluorescent microscope.
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Figure 5.7  Identification of Arr4-interacting proteins in yeast.  (A) and (B) BY4741 cells
were transformed with either pRS316-FLAG-ARR4 or pRS316-MYC-ARR4 (each plasmid
is single copy and expression is driven by the endogenous ARR4 promoter).  6 liters of cells
were grown to mid-log phase and treated with water or 3 µM ?-factor and harvested.
Extracts were purified using FLAG-M2 antibody resin (Sigma), and eluted using 3x-FLAG
peptide.  Eluant was resolved by 12 % SDS-PAGE and either (A) staining with Silver stain
(Bio-Rad), (B) immunoblotting with anti-FLAG antibody, Orbitrap LC/MS analysis (data not
shown).
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To test whether this was a pheromone-dependent breakdown product of Arr4, we also probed
with anti-FLAG antibodies.  Although some breakdown did appear to be pheromone
dependent, the 25 kDa band observed in the silver stained gel did not appear in the gel
probed for FLAG (Figure 5.7 B).  Since Arr4 was only tagged with FLAG on its N-terminus,
this could still be a C-terminal breakdown product.
The Orbitrap LC/MS has been completed, but the extensive data analysis is just
underway.  To date, we have simply analyzed each sample (FLAG-Arr4 with pheromone,
FLAG-Arr4 without pheromone, and MYC-Arr4 with pheromone) using a very stringent
95% confidence interval for peptide presence or absence. It is not uncommon to vary the
confidence interval threshold of detection.  A better understanding of the data will result
from a detailed analysis of the data set across confidence intervals, and also upon further
ratiometric analysis between the samples to define quantitatively how protein presence varies
between conditions.  These analyses will be performed in the very near future.
From the existing data set (Table 5.2) some interesting information has arisen. Only a
few proteins were identified that bound specifically to Arr4 in the presence of pheromone.
Two of these proteins, Tdh1 and Tdh3, are proteins that are known to be resident in the yeast
lipid particle.  The lipid particle is an intracellular compartment thought to function as a
reserve center for cellular lipids.  It is thought to be comprised mostly of triglycerols and
sterol esters, and only a few proteins (6).  Some lipid particle proteins, like Erg1, are also
resident in ER, establishing a relationship between these two compartments (87).  As
mentioned previously, Arr4 is known to exist in the ER, and is known genetically known to
play a role in Golgi-to-ER trafficking (hence the name Get3, an alias for Arr4) (131).  These
findings suggest that in the presence of pheromone, Arr4 also exists at the lipid particle.  It is
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not clear how Arr4 at the lipid particle would regulate Gpa1 signaling, but at least one other
lipid particle protein, Erg6, is known to be required for proper mating (77).  In future studies,
we will first confirm pheromone dependent interaction between Arr4 and lipid particle
subunits, as well as other proteins that are uncovered after our detailed analysis.   Following
these studies, we will test the effect of gene deletions on Gpa1/Arr4 localization, signaling,
and mating.
The studies presented in Chapter IV of this thesis and in this section provide evidence
that Arr4 is a bona fide component of the yeast mating pathway.  In addition to the finding
that arr4 deletion results in hampered signaling through the mating pathway, here we present
evidence that Arr4 translocates in response to pheromone treatment and physically interacts
with a new subset of proteins.  Evident both in our microscopy analysis as well as in our
mass spectrometry analysis is the fact that less than 100% of Arr4 translocates to intracellular
puncta in response to pheromone.  Thus, we anticipate that a more detailed analysis of this
data set will result in a better understanding of pheromone dependent changes in Arr4
localization and function.  Nonetheless, our preliminary findings suggest that Arr4
translocates to lipid particles in response to pheromone treatment.  These data provide the
first preliminary evidence that Gpa1 can be activated from an intracellular location, and in
general, these findings further develop the idea that G proteins can function from intracellular
locations.
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GPA1
N388D
: A NOVEL TOOL FOR THE IDENTIFCATION OF GEFS FOR G?
SUBUNITS
Summary
G protein coupled receptors (GPCRs) are the canonical activators of heterotrimeric G
protein signaling pathways.  Since the identification that GPCRs were heptahelical
membrane spanning receptors, the search for other activators of G? subunits has typically
involved identifying proteins that were structurally related to GPCRs.  Screening in this way
has caused the field to overlook proteins that are functional, but not structural, GPCR
analogs.  In recent years, many in the field have begun to search for G protein activators
using functional criteria, and as a result, a number of non-receptor activators have been
identified.  Here, we will discuss a novel tool for the identification of G? activators: a
dominant negative G? mutant.
Non-receptor activators of heterotrimeric G? subunits
G protein coupled receptors (GPCRs) regulate a wide variety of physiologically
relevant pathways and are the most commonly targeted proteins in all of medicine (61, 169).
When ligand bound, the receptor functions as a guanine nucleotide exchange factor (GEF),
stabilizing the nucleotide-free form of the G protein, thus allowing exchange of GDP for
GTP (141).  The process by which receptors are able to activate G? subunits has been the
subject of intense investigation, as it is still unclear exactly how this occurs.  The elusive
mechanism of G?  activation is further complicated by the existence of non-receptor
activators that bear no structural or sequence similarity to GPCRs, yet also function as GEFs.
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The existence of these proteins was likely overlooked for so long because screens for
activators of G? subunits have focused on identifying proteins with structural, not functional
similarity to GPCRs.   However, in recent years, investigators have returned to identifying
activators using functional criteria, and the result has been the discovery of at least 3
unrelated families of non-receptor G? activators: Ric-8 and its homologs, the AGS family,
and most recently the yeast protein Arr4 (26, 88, 151).  All three discoveries were made with
the help of the genetic tools available in model organisms such as S. cerevisiae and C.
elegans.  Ric-8 and AGS proteins have been reviewed extensively elsewhere (15, 65); here
we will focus on the dominant-negative screening method used to identify the yeast protein
Arr4.
Dominant negative mutant screen
Dominant negative mutants are loss-of-function alleles that when over-expressed also
block the activity of the wild-type protein.  Dominant negative activity is often achieved if
the mutant product is still capable of interacting with the same binding partners, but has lost
functional properties.  The classic example is a transcription factor that contains a DNA
binding domain, but lacks a transactivation domain.  Dominant negative mutants can be
potent tools for studying protein function.
Recently, two different mutations in the yeast G? subunit Gpa1 were claimed to
cause constitutive activity.  Paradoxically, over-expression of the two mutants caused
opposite phenotypes.  Expression of Gpa1Q323L caused signal activation (62).  Expression of
Gpa1N388D caused signal inhibition (147). Gpa1Q323L had already been characterized
biochemically, and shown to bind but not hydrolyze GTP (3). To resolve this debate, we
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characterized the Gpa1N388D mutant, and found that it functioned as a dominant negative
(171).  Gpa1N388D could still bind to and hydrolyze GTP, and still bound to G??.  The
dominant negative activity arose because this mutant formed a stable complex with the
ligand-bound GPCR Ste2.  The critical finding was that Ste2 bound better to the Gpa1N388D
mutant than to the wild-type version of Gpa1, but this was only true of the ligand-bound
receptor (Figure 5.8).  Stated differently, the dominant negative mutant did not simply exhibit
enhanced binding to receptors, it exhibited enhanced binding to GEFs.
It is not clear why the “ND” mutant binds GEFs, but the simplest explanation is that
Gpa1N388D is nucleotide-empty or somehow mimics the empty state.  Indeed, Gpa1N388D has
at least two hallmarks of empty G? subunits: specific interaction with activated receptors in
vivo and protein instability in vitro (53).  In our previous study, adding the “ND” mutation to
either Gpa1 or G?i1 resulted in decreased protein yield, decreased activity, and increased
sensitivity to time and temperature in vitro; and activating the receptor stabilized the protein
in vivo (171). One reason “ND” might favor the empty state could be decreased affinity of
the G protein for guanine nucleotide.  Asn-388 lies within the conserved NKXD motif,
required for guanine recognition (141).  Structural evidence shows that both the Asn and the
Asp in this motif form hydrogen bonds with the guanine ring, and other investigators have
found that mutational substitution of within this region is sufficient to switch nucleotide
specificity from guanine to xanthosine (141, 172).
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Figure 5.8  Stable interaction between Gpa1
N388D
 and the ligand-bound receptor Ste2.
(A) ste7? gpa1? mutant strain was transformed with plasmids containing STE7 under the
control of the GAL1/10 promoter and either wild-type GPA1 or GPA1N388D under the control
of the GALH promoter.  Cells were plated onto galactose-containing medium and exposed to
?-factor pheromone (counter-clockwise from top, 75, 25, 8, 0 µg).  The resulting zone of
pheromone-dependent cell growth was recorded after 2 days.  (B) To determine if Gpa1N388D
forms a stable complex with the receptor, diploid cells (strain YPH501) were transformed
with plasmids containing either tagged or untagged STE2, STE4/18 (G??), and either wild-
type or mutant GPA1 and then treated with 2.5 µM ?-factor (?-MF) as indicated.  Detergent-
solubilized lysates were immunoprecipitated with anti-FLAG antibodies.  Samples of total
cell lysates (Applied) and purified protein (IP) were resolved by 7.5% SDS-PAGE and
subjected to immunoblotting with antibodies that detect Ste2 (FLAG Ab) and Gpa1.  Data
shown are representative of three independent experiments.  Arrows indicate the proteins
specifically detected by the indicated antibodies.
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Identification of the non-receptor GEF Arr4
If our hypothesis is correct, that Gpa1N388D had dominant negative activity because it
mimics the empty state, this mutant will selectively interact with any protein that stabilizes
the empty state. Thus we reasoned that the selective interaction between a GEF (ligand
bound Ste2) and Gpa1N388D could be a useful tool to match receptors to their cognate G?
subunits and also to screen for novel GEFs. This is particularly valuable in light of the fact
that GEFs for G? subunits lack any physical, structural, or sequence similarity to allow for
their identification in silico.
Using this knowledge, we designed a screen in yeast for novel GEFs for Gpa1.  We
began by compiling a list all proteins that have previously been found to interact with Gpa1.
This list was collected from a combination of published data (yeast 2-hybrid, genome-wide
interaction screens, etc.) and unpublished data from our own lab.  Our screen involved 2
steps: first determining which proteins interact with Gpa1 in a nucleotide-dependent manner,
and second, identifying which proteins bound selectively to the dominant negative mutant
Gpa1N388D.  GDP-selective binding is the only characteristic maintained across all GEFs, and
as described above, selective binding to the Gpa1N388D mutant is a characteristic we believe
to be unique to GEFs.  We identified 7 proteins that interact with the GDP-bound form of
Gpa1, but not the GTP-bound form (see Chapter IV).  Of those 7 proteins, we identified
2—Arr4 and Reg1—that bind preferentially to Gpa1N388D.  We subsequently found in vitro
that Arr4 binds to the G protein in a manner similar to receptors and functions as a GEF for
Gpa1, and in vivo that Arr4 functions in cooperation with receptors to promote activation of
the mating signal through Gpa1 (88).
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Figure 5.9  Reg1 regulates Gpa1 signaling and localization. BY4741 or BY4741-derived
cells lacking REG1 were transformed with pAD4M, pAD4M-REG1 or pRS316-REG1.  Cells
were also transformed with the reporter plasmid pRS423-FUS1-lacZ.  Data are basal ?-
galactosidase activity; results are the mean ± SEM for 3 individual experiments each
performed in triplicate.  (B) Wild-type and reg1? cells were co-transformed with integrating
plasmids pRS406-GPA1-GFP.  Cells were visualized using a fluorescent microscope.
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Considerations when using the “ND” mutant
The major limitation in using the dominant negative G? is the instability of this
protein.  In our previous works, we have combated the poor expression associated with
Gpa1N388D using a couple different means.  In our recent published work, rather than
monitoring absolute binding, we focused on binding relative to total expression, as a crude
measure of affinity (see Chapter IV). In other studies we used diploid yeast cells, which do
not express most of the mating components including G?, ??, and receptor; we found that
over-expression of the receptor stabilized the expression of the Gpa1N388D mutant (171).
Although diploidizing cells is not likely to be of widespread usefulness, receptor-mediated
stability provides a universal mechanism for stabilizing this mutant for study and another
potential screening phenotype.  Future studies aimed at identifying GEFs could focus on
identifying proteins that when over-expressed enhance ND mutant stability.  Furthermore,
identifying receptor-derived peptides that enhance ND mutant stability could provide insight
into the elusive mechanism by which GPCRs function as GEFs.  In addition, identifying
secondary mutations that stabilize the Gpa1N388D mutant but do not block its activity will be
of immense value.
Reg1—Validation of the “ND Screen”
Our finding that Arr4 is a GEF for validates the Gpa1N388D screening principle.
Rigorous validation, however, will require that both proteins identified in the screen are
GEFs.  Reg1 is the regulatory subunit of a protein phosphatase, known to regulate the
expression of glucose repressible genes in yeast (158).  Our preliminary attempts to purify
Reg1 from bacteria for characterization in vitro have failed; Reg1 is a 112 kDa protein with
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no known domain structure.  Purification from other sources, such as insect cell expression
systems or direct purification from yeast, has not been attempted.  In the absence of in vitro
biochemistry, it is difficult to make any conclusions about Reg1 function, but some in vivo
evidence does exist suggesting that Reg1 regulates Gpa1 function.  In addition to the GEF-
like binding profile exhibited by Reg1, when mating pathway activation is monitored at
the level of gene transcription, Reg1 associated phenotypes are consistent with it functioning
as a GEF. Over-expression of REG1 results in increased pathway activation downstream of
Gpa1, whereas deletion of REG1 results in a decrease in basal pathway activity (Figure 5.9
A).  Similar results were found for the GEF Arr4 as well as the GPCR Ste2 (88).
Furthermore, in another screen performed by our group, REG1 deletion was found to block
G? signaling in yeast (136).  This screen utilized a constitutively active mutant, Gpa1Q323L,
which should have bypassed the need for GEFs, however, other non-receptor GEFs such as
Ric-8a, have been shown to regulate protein activity and protein localization (100).  A similar
case could be made for Reg1.  In fact, preliminary data suggests that this might be the case;
we found that Gpa1-GFP mislocalizes in cells that have REG1 deleted (Figure 5.9 B).
In conclusion, we’ve characterized the dominant negative mutant Gpa1N388D, and
used this mutant to identify the GEF Arr4.  Future studies in yeast will likely include
characterization of Reg1, and also an expanded genome-level screen for Gpa1N388D
interacting partners.  However, studies in yeast are only the beginning.  This residue is
conserved in all G proteins, and it is likely that similar mutations in other G? subunits will
also function as dominant negatives. Whether as a tool for identifying new GEFs, or for
revealing the mechanism of receptor-mediated activation, this dominant negative could
provide a unique resource for studying G? activation.  Studies of this type would benefit
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from a greater understanding of this mutant.  For example, it is not clear why this mutation
results in a dominant negative phenotype, and it will likely remain unresolved until structural
data is collected for this mutant.  Structural data will also resolve whether or not it is possible
to separate the dominant negative activity from the instability of the ND mutant protein.
Identifying GEFs for G? subunits has long been a difficult endeavor; the development of
new tools, such as dominant negative G? mutants, can only help in answering these, and
many other fundamental questions.
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EXPERIMENTAL PROCEDURES
Strains and plasmids—Standard methods for growth, maintenance, and
transformation of yeast and bacteria and for the manipulation of DNA were used throughout.
Yeast Saccharomyces cerevisiae strains used in this study were BY4741 (MATa  leu2?
met15? his3? ura3?), BY4741-derived mutants constructed using the KanMX G418-
resistence marker (Yeast Deletion Clones, Invitrogen; originally purchased from Research
Genetics), BY4741-derived strains containing a C-terminal tandem affinity purification
(TAP) tag (Yeast TAP-Fusion Library, Open Biosystems), and DC17 (MAT? his1). The
arr4? strain from Research Genetics did not produce a phenotype that could be rescued by
addition of a plasmid-borne copy of ARR4, so the strain was remade by PCR amplification of
the original deletion cassette and transformation of the parent strain.
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Yeast shuttle plasmids used were pRS305 (ampR, LEU2) and pAD4M (2µm, ampR,
LEU2, ADH1 promoter and terminator). Expression plasmids described previously were
pAD4M-GPA1 (139), pAD4M-GPA1Q323L (62), pRS423-FUS1-lacZ (74), pAD4M-
GPA1N388D (171), pAD4M-ARR4 (88), pRS406-GPA1-GFP (164).  pRS406-GFP-Arr4 was
created by inserting the ARR4 ORF into pUG36 (N-terminal GFP vector) using the restriction
sites XmaI (FWD) and SalI (REV).  The XmaI-SalI fragment was then subcloned into
pRS406.  FLAG- and MYC-ARR4 were created using the pRS316FLAG- and pRS316MYC-
plasmids created previously; ARR4 was subcloned into these vectors using pRS305-ARR4 as
an insert (174).
E. coli expression of 6xHIS fusion proteins—6xHIS-Gpa1 expression plasmid was
described previously (4). Plasmids for bacterial expression of 6xHIS-Arr4 fusion protein
were generated by ligation-independent cloning as described previously (143). ARR4 was
PCR-amplified from genomic DNA (Forward primer: 5’—TAC TTC CAA TCC AAT CGC
ATG GAT TTA ACC GTG GAA CC—3’; reverse primer: 5’—TTA TCC ACT TCC AAT
GCG CTA CTA TTC CTT ATC TTC TAA CTC—3’), annealed to the gapped 6XHIS vector
pMCSG7 or a version of pMCSG7 modified to contain a GST tag (from Jason Snyder and
John Sondek, Univ. North Carolina), and transformed into BL21 (DE3) E. coli. Overnight
cultures from single colonies grown at 37°C in Luria Broth (LB) supplemented with 100
µg/ml carbenicillin were diluted 1:100 into fresh media and grown to A600 nm ~ 0.7. 6xHIS-
Gpa1 and 6xHIS-Gpa2 expression was induced by addition of 0.1 mM isopropyl ?-D-1-
thiogalactopyranoside and incubation at room temperature for 5 h with shaking. 6xHIS-Arr4
was induced by addition of 0.1 mM isopropyl ?-D-1-thiogalactopyranoside and incubation at
18°C for 14 h. Cells were harvested by centrifugation, resuspended in Buffer A (20 mM Tris
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pH 8.0, 200 mM NaCl, 5% glycerol, 1 mM DTT), and homogenized using an Emulsiflex-C5
Homogenizer (Avestin Inc.). Lysates were clarified by centrifugation at 12,000 x g  for 30
min and the resulting supernatant was mixed with Ni-NTA resin (Amersham Pharmacia
Biotech AB) equilibrated with Buffer A, and incubated for 2 h at 4°C with gentle rotation.
Resin was collected by centrifugation at 500 x g  for 5 min and washed 3 times in Buffer A,
and eluted in 250mM imidazole. Elution was concentrated using Vivaspin concentrators
(Vivascience AG).
Steric-exclusion chromatography—Purified protein was subject to steric-exclusion
chromatography using an Akta FPLC system and a Sephacryl 26/60 S200 column (GE
Healthcare). Protein was equilibrated in 20 mM Tris pH 8.0, 100 mM NaCl, 5% glycerol, 1
mM DTT, 2 mM MgCl2, 20 µM GDP (when added), and 150 nM CuSO4 (when added).
Protein was separated at 0.5 ml/min, and collected in 7 ml fractions. UV absorbance of each
fraction (A280nm) was recorded and data analyzed using the UNICORN program associated
with the FPLC system. A 20 µl sample from each fraction was separated by SDS-PAGE and
either probed with penta-HIS antibody or stained with Coomassie Brilliant Blue R250 (Bio-
Rad).
MAPK phosphorylation assays—Yeast strains were grown with shaking at 30°C in
selective media to A600 nm ~0.8 and treated with either 3 µM ?-factor pheromone or 500 mM
KCl. Samples were removed at timed intervals, collected by centrifugation, and stored at -70°
C. To prepare extracts, cell pellets were thawed on ice and resuspended in 250 µl of ice cold
TCA buffer (10 mM Tris pH 8.0, 10% trichloroacetic acid, 25 mM NH4OAc, 1 mM EDTA).
Cells were disrupted by vortexing with 100 µl of glass beads in 5 x 1 min bursts with chilling
on ice in between. Lysates were transferred to new tubes and centrifuged for 10 min at
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16,000 x g at 4°C. Pellets were resuspended in 0.1 M Tris pH 11.0, 3% SDS, and boiled for 5
min, then centrifuged at 16,000 x g. The resulting supernatant was separated and protein
concentration was determined using the DC protein assay (Bio-Rad Laboratories). 20 µg of
protein in 2x SDS-PAGE sample buffer was used per time point. MAPK phosphorylation
was determined by 12% SDS-PAGE and immunoblotting with p44/42 MAPK antibody or
p38 MAPK antibody at 1:500 (Cell Signaling Technology). Densitometry of developed blots
was determined using ImageJ. The MAPK signaling defect in arr4 cells was rescued by a
plasmid-borne copy of ARR4 (data not shown).
Transcription reporter assay—Cells were transformed with pRS423-FUS1-lacZ, and
?-galactosidase activity was determined as described previously (74). Briefly, cells were
grown to A600 nm ~ 0.8, and treated with ?-factor mating pheromone for 90 min. 1 mM
fluoro-di-D-galactopyranoside (FDG) diluted in 25 mM PIPES pH 7.2 was added, and cells
were incubated at 37°C in the dark for 45 min. Reaction was quenched by addition of
Na2CO3 to a final concentration of 200 µM and fluorescence at 485-530 nm was measured
using a VersaMax optical plate reader. The transcription-reporter defect in arr4 cells was
rescued by a plasmid-borne copy of ARR4 (data not shown).
Microscopy analysis. Cells expressing single-copy, integrated GFP-tagged gene
fusions were visualized by differential interference contrast (DIC) and fluorescence
microscopy using a Nikon eclipse E600EN, photographed with a Hamamatsu digital camera,
and analyzed with MetaMorph Version 5.0 software.
FLAG-IP.  Cells expressing FLAG-tagged ARR4 were grown to A600nm ~ 0.8, treated
with ?-factor mating pheromone to a final concentration of 3 µM, and grown for an
additional 90 minutes.  Cells were harvested by centrifugation, lysed using a bead beater, and
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purified using M2 anti-FLAG resin, according to the manufacturer’s protocol (Sigma).
Protein was eluted off of M2 FLAG resin using 3x-FLAG peptide.
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